ZRANB2 B-RNA
is O
up O
- O
regulated O
in O
glioma B-Disease
tissues O
and O
glioma B-Disease
cells O
. O

Zhang O
et O
al O
evaluated O
the O
serum O
exosomal O
expression O
of O
SNHG16 B-RNA
in O
bladder B-Disease
cancer I-Disease
patients O
and O
found O
that O
SNHG16 B-RNA
expression O
was O
correlated O
with O
TNM O
stage O
and O
invasion O
and O
predicted O
poor O
prognosis O

ZFAS1 B-RNA
was O
upregulated O
in O
epithelial B-Disease
ovarian I-Disease
cancer I-Disease
tissues O
, O
and O
was O
negatively O
correlated O
to O
the O
overall O
survival O
rate O
of O
patients O
. O

ZFAS1 B-RNA
was O
highly O
expressed O
in O
thyroid B-Disease
cancer I-Disease
compared O
to O
normal O
samples O
. O

ZFAS1 B-RNA
expression O
was O
up O
- O
regulated O
, O
while O
miR O
- O
432 O
- O
5p O
expression O
was O
down O
- O
regulated O
in O
both O
glioma B-Disease
tissues O
and O
cells O
. O

ZFAS1 B-RNA
expression O
was O
increased O
in O
melanoma B-Disease
tissues O
and O
cells O
compared O
with O
normal O
controls O
. O

ZEB1 B-RNA
- I-RNA
AS1 I-RNA
regulated O
gastric B-Disease
cancer I-Disease
cells O
migration O
, O
invasion O
and O
EMT O
process O
. O

ZBTB7A B-RNA
Enhances O
Osteosarcoma O
Chemoresistance O
by O
Transcriptionally O
Repressing O
lncRNA O
LINC00473 B-RNA
- I-RNA
IL24 I-RNA
Activity O
. O

YAP1 B-RNA
enhances O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
of O
gastric B-Disease
cancer I-Disease
in O
vitro O
and O
in O
vivo O
. O

Yang O
et O
al O
reported O
that O
SNHG16 B-RNA
expression O
was O
significantly O
increased O
in O
human O
ovarian B-Disease
cancer I-Disease
( O
OC O
) O
as O
compared O
to O
normal O
ovarian O
tissue O
. O

XIST B-RNA
was O
significantly O
upregulated O
in O
neuroblastoma B-Disease
tissues O
( O
n O
= O
30 O
) O
and O
cells O
lines O
, O
and O
it O
was O
statistically O
associated O
with O
the O
age O
and O
International O
Neuroblastoma O
Staging O
System O
( O
INSS O
) O
staging O
in O
neuroblastoma B-Disease
patients O
. O

Xist O
transcripts O
are O
present O
in O
P10 O
female B-Disease
embryonal I-Disease
carcinoma I-Disease
cells O
with O
two O
active O
X O
chromosomes O
and O
that O
the O
Xist O
genes O
on O
both O
X O
chromosomes O
are O
expressed O
. O

XIST B-RNA
Induced O
by O
JPX B-RNA
Suppresses O
Hepatocellular O
Carcinoma O
by O
Sponging O
miR B-RNA
- I-RNA
155 I-RNA
- I-RNA
5p I-RNA
. O

XIST B-RNA
and O
CREB1 B-RNA
were O
overexpressed O
whereas O
miR B-RNA
- I-RNA
329 I-RNA
- I-RNA
3p I-RNA
was O
low O
- O
expressed O
in O
glioma B-Disease
tumors O
and O
cells O
compared O
with O
the O
normal O
counterparts O
. O

Therefore O
, O
these O
findings O
revealed O
that O
LINC00511 B-RNA
functions O
as O
an O
oncogene O
through O
the O
PTEN O
- O
AKT O
- O
FOXO1 O
signaling O
pathway O
in O
lung B-Disease
cancer I-Disease
, O
providing O
a O
potential O
target O
of O
metastasis O
in O
lung B-Disease
cancer I-Disease
. O

Knockdown O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
88732 I-RNA
induced O
glioma B-Disease
cell O
apoptosis O
and O
inhibited O
glioma B-Disease
cell O
migration O
, O
invasion O
, O
and O
epithelial O
- O
mesenchymal O
transition O
( O
EMT O
) O
. O

We O
then O
found O
that O
the O
expression O
of O
FTX B-RNA
and O
miR B-RNA
- I-RNA
342 I-RNA
- I-RNA
3p I-RNA
was O
associated O
with O
progression O
of O
gliomas O
. O

We O
showed O
that O
circFNDC3B O
increased O
migration O
and O
invasion O
in O
gastric B-Disease
cancer I-Disease
( O
GC O
) O
. O

We O
show O
that O
LINC00963 B-RNA
upregulation O
is O
correlated O
with O
aggressive O
parameters O
of O
breast B-Disease
cancer I-Disease
. O

we O
observed O
that O
UCA1 B-RNA
was O
significantly O
upregulated O
in O
chemoresistant O
retinoblastoma B-Disease
tissues O
and O
multidrug O
resistant O
retinoblastoma B-Disease
cell O
lines O
and O
predicted O
an O
unfavorable O
overall O
survival O
. O

We O
observed O
that O
DBH B-RNA
- I-RNA
AS1 I-RNA
was O
distinctly O
overexpressed O
in O
osteosarcoma B-Disease
tissue O
and O
cells O
, O
and O
associated O
with O
lymph O
node O
status O
and O
metastasis O
status O
. O

We O
further O
showed O
that O
lincRNA B-RNA
- I-RNA
p21 I-RNA
inhibited O
prostate B-Disease
cancer I-Disease
cell O
proliferation O
and O
colony O
formation O
in O
vitro O
and O
reduced O
rate O
of O
prostate B-Disease
cancer I-Disease
cell O
population O
growth O
in O
vivo O
. O

we O
found O
that O
MAPT B-RNA
- I-RNA
AS1 I-RNA
is O
overexpressed O
in O
breast B-Disease
cancer I-Disease
but O
not O
in O
triple B-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
( O
TNBC O
) O
, O
and O
that O
high O
expression O
of O
MAPT B-RNA
- I-RNA
AS1 I-RNA
was O
correlated O
with O
better O
patient O
survival O
. O

We O
found O
that O
LINC01234 B-RNA
expression O
was O
significantly O
upregulated O
in O
colon O
cancer O
tissues O
and O
was O
associated O
with O
a O
shorter O
survival O
time O
. O

We O
found O
that O
expression O
of O
CCAT2 B-RNA
was O
up O
- O
regulated O
in O
glioma B-Disease
tissues O
and O
significantly O
correlated O
with O
the O
advanced O
tumor O
stage O
( O
III O
/ O
IV O
) O
. O

We O
first O
demonstrated O
that O
circMTO1 B-RNA
was O
an O
important O
circRNA O
frequently O
downregulated O
in O
bladder O
cancer O
tissue O
, O
and O
lower O
circMTO1 B-RNA
levels O
were O
positively O
correlated O
with O
bladder O
cancer O
patients O
' O
metastasis O
and O
poorer O
survival O
. O

We O
demonstrated O
that O
LINC00312 B-RNA
induces O
lung O
adenocarcinoma O
metastasis O
and O
VM O
through O
direct O
binding O
to O
YBX1 O
. O

UXT B-RNA
- I-RNA
AS1 I-RNA
was O
found O
to O
be O
significantly O
upregulated O
in O
colorectal O
cancer O
( O
CRC O
) O
and O
high O
expression O
levels O
of O
UXT B-RNA
- I-RNA
AS1 I-RNA
were O
significantly O
associated O
with O
poor O
prognosis O
in O
CRC O
patients O
. O

Upregulation O
of O
the O
long O
noncoding O
RNA O
ADPGK B-RNA
- I-RNA
AS1 I-RNA
promotes O
carcinogenesis O
and O
predicts O
poor O
prognosis O
in O
gastric O
cancer O
. O

Upregulation O
of O
OIP5 B-RNA
- I-RNA
AS1 I-RNA
Could O
Predict O
Unfavorable O
Prognosis O
in O
Thyroid O
Cancer O
. O

Upregulation O
of O
lncRNA O
HNF1A B-RNA
- I-RNA
AS1 I-RNA
promotes O
cell O
proliferation O
and O
metastasis O
in O
osteosarcoma O
through O
activation O
of O
the O
Wnt O
/ O
β O
- O
catenin O
signaling O
pathway O
. O

Upregulated O
Meg3 B-RNA
expression O
suppresses O
tumorigenesis O
of O
epithelial O
ovarian O
carcinoma O
in O
vivo O

Upregulated O
lncRNA O
- O
PCAT1 B-RNA
is O
closely O
related O
to O
clinical O
diagnosis O
of O
multiple O
myeloma O
as O
a O
predictive O
biomarker O
in O
serum O
. O

Up O
- O
regulated O
lncRNA O
XIST B-RNA
contributes O
to O
progression O
of O
cervical O
cancer O
via O
regulating O
miR B-RNA
- I-RNA
140 I-RNA
- I-RNA
5p I-RNA
and O
ORC1 B-RNA
. O

Upregulated O
expression O
of O
MNX1 B-RNA
- I-RNA
AS1 I-RNA
long O
noncoding O
RNA O
predicts O
poor O
prognosis O
in O
gastric O
cancer O
. O

TUG1 B-RNA
had O
more O
expression O
in O
pancreatic O
cancer O
tissues O
than O
that O
in O
para O
- O
carcinoma O
tissues O
. O

TTN B-RNA
- I-RNA
AS1 I-RNA
overexpression O
inhibits O
ovarian O
cancer O
cell O
proliferation O
, O
colony O
formation O
but O
promotes O
apoptosis O
. O

Thus O
, O
our O
findings O
indicated O
that O
ZFAS1 B-RNA
could O
exhibit O
a O
tumor O
oncogenic O
role O
in O
glioma B-Disease
progression O
by O
regulating O
EMT O
and O
Notch O
signaling O
pathway O
. O

This O
study O
aims O
to O
show O
that O
long O
noncoding O
RNA O
( O
lncRNA O
) O
Linc02023 B-RNA
aberrant O
downregulation O
in O
colorectal O
cancer O
correlates O
positively O
with O
the O
expression O
of O
PTEN O
and O
CDKN2B O
but O
negatively O
with O
the O
tumor O
size O
in O
patients O
and O
xenografted O
mouse O
models O
. O

These O
results O
suggest O
that O
lnc B-RNA
- I-RNA
Sox5 I-RNA
, O
which O
was O
stabilized O
by O
HuR O
, O
could O
regulate O
carcinogenesis O
of O
tongue O
cancer O
and O
may O
serve O
as O
a O
predicted O
target O
for O
tongue O
carcinoma O
therapies O
. O

These O
results O
indicated O
that O
lncR O
SNHG15 B-RNA
plays O
an O
oncogenic O
role O
during O
colon O
cancer O
progression O
. O

These O
findings O
indicate O
that O
SNHG1 B-RNA
can O
affect O
colorectal O
cancer O
cells O
growth O
in O
vitro O
and O
in O
vivo O
. O

These O
data O
suggest O
that O
lnc B-RNA
- I-RNA
TSI I-RNA
reduced O
renal O
fibrogenesis O
through O
negative O
regulation O
of O
the O
TGF O
- O
β O
/ O
Smad O
pathway O
. O

These O
data O
indicated O
that O
SNHG20 B-RNA
knockdown O
inhibited O
the O
tumour O
growth O
of O
bladder O
cancer O
cells O
in O
a O
mouse O
xenograft O
model O
and O
was O
associated O
with O
reduced O
Wnt O
/ O
β O
- O
catenin O
siglling O
activity O
. O

The O
up O
- O
regulation O
of O
long O
non O
- O
coding O
RNA O
CCAT2 B-RNA
indicates O
a O
poor O
prognosis O
for O
prostate B-Disease
cancer I-Disease
and O
promotes O
metastasis O
by O
affecting O
epithelial O
- O
mesenchymal O
transition O
. O

The O
statistical O
significance O
data O
suggested O
that O
lncRNA O
BDNF B-RNA
- I-RNA
AS I-RNA
linc00467 B-RNA
were O
downregulated O
in O
primary B-Disease
breast I-Disease
cancer I-Disease
, O
whereas O
, O
they O
showed O
no O
significant O
change O
in O
breast O
cancer O
tissues O
compared O
with O
adjacent O
tissues O
in O
multiple O
primary O
neoplasms O
. O

The O
results O
showed O
that O
the O
expression O
of O
lncRNA O
H19 B-RNA
and O
miR B-RNA
- I-RNA
675 I-RNA
was O
up O
- O
regulated O
in O
patients O
with O
chronic O
hepatitis O
B O
( O
n O
= O
20 O
) O
. O

The O
results O
demonstrated O
that O
CCEPR B-RNA
expression O
was O
significantly O
higher O
in O
colorectal B-Disease
cancer I-Disease
tissues O
when O
compared O
with O
paired O
adjacent O
normal O
tissues O
. O

The O
PVT1 B-RNA
expressions O
were O
significantly O
enhanced O
in O
tissues O
of O
pituitary B-Disease
adenoma I-Disease
and O
cancer O
cells O
. O

The O
present O
study O
showed O
an O
increase O
of O
SNHG7 B-RNA
expression O
in O
malignant B-Disease
melanoma I-Disease
tissues O
and O
cell O
lines O
. O

The O
present O
study O
revealed O
that O
lncRNA O
DRHC B-RNA
was O
downregulated O
and O
lncRNA O
Hox B-RNA
transcript O
antisense O
RNA O
( O
HOTAIR B-RNA
) O
was O
upregulated O
in O
tumor O
tissues O
compared O
with O
adjacent O
healthy O
tissues O
in O
patients O
with O
triple B-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
( O
TNBC O
) O
. O

The O
present O
study O
found O
that O
tissues O
from O
aortic B-Disease
aneurysm I-Disease
patients O
and O
hypoxic O
aortic O
smooth O
muscle O
cells O
showed O
aberrant O
high O
expression O
of O
the O
cyclic O
RNA O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
595 I-RNA
, O
as O
demonstrated O
by O
polymerase O
chain O
reaction O
array O
screening O
. O

The O
present O
data O
demonstrated O
that O
lncRNA O
- O
BLACAT1 B-RNA
was O
upregulated O
in O
breast B-Disease
cancer I-Disease
, O
which O
promoted O
breast B-Disease
cancer I-Disease
cell O
proliferation O
and O
metastasis O
via O
down O
- O
regulating O
miR O
- O
150 O
- O
5p O
by O
targeting O
CCR2 O
expression O
. O

the O
overexpression O
of O
LINC00365 B-RNA
and O
SCGB2A1 B-RNA
inhibited O
cell O
viability O
and O
induced O
cell O
apoptosis O
through O
the O
inhibition O
of O
the O
NF O
- O
κ O
B O
signaling O
pathway O
in O
breast B-Disease
cancer I-Disease
cells O
. O

The O
long O
non O
- O
coding O
RNA O
SUMO1P3 B-RNA
facilitates O
breast B-Disease
cancer I-Disease
progression O
by O
negatively O
regulating O
miR B-RNA
- I-RNA
320a I-RNA
; O
SUMO1P3 B-RNA
binds O
to O
miR B-RNA
- I-RNA
320a I-RNA
, O
which O
has O
been O
identified O
as O
a O
tumor O
suppressor O
in O
various O
cancers O
, O
including O
breast B-Disease
cancer I-Disease

The O
long O
non O
- O
coding O
RNA O
MALAT1 B-RNA
interacted O
with O
miR B-RNA
- I-RNA
218 I-RNA
modulates O
choriocarcinoma B-Disease
growth O
by O
targeting O
Fbxw8 O
; O
miR B-RNA
- I-RNA
218 I-RNA
- O
mediated O
Fbxw8 O
regulation O
was O
required O
for O
MALAT1 B-RNA
- O
induced O
choriocarcinoma B-Disease
cell O
proliferation O

The O
long O
noncoding O
RNA O
LINC00473 B-RNA
, O
a O
target O
of O
microRNA B-RNA
34a I-RNA
, O
promotes O
tumorigenesis O
by O
inhibiting O
ILF2 O
degradation O
in O
cervical B-Disease
cancer I-Disease
; O
LINC00473 B-RNA
directly O
interacted O
with O
ILF2 O
and O
suppressed O
its O
degradation O

The O
long O
non O
- O
coding O
RNA O
HOXB B-RNA
- I-RNA
AS3 I-RNA
regulates O
ribosomal O
RNA O
transcription O
in O
NPM1 O
- O
mutated O
acute B-Disease
myeloid I-Disease
leukemia I-Disease

The O
level O
of O
long O
noncoding O
RNA O
cancer O
susceptibility O
candidate O
2 O
( O
CASC2 B-RNA
) O
and O
PTEN O
expression O
was O
upregulated O
by O
the O
ginsenoside O
Rg3 O
treatment O
, O
and O
CASC2 B-RNA
/ O
PTEN O
signaling O
was O
involved O
in O
the O
ginsenoside O
Rg3 O
- O
induced O
cell O
growth O
suppression O
and O
apoptosis O
in O
GEM O
- O
resistant O
pancreatic B-Disease
cancer I-Disease
cells O
. O

The O
expression O
of O
one O
of O
the O
long O
noncoding O
RNAs O
, O
CARLo B-RNA
- I-RNA
5 I-RNA
, O
is O
significantly O
correlated O
with O
the O
rs6983267 O
allele O
associated O
with O
increased O
cancer B-Disease
susceptibility O
. O

The O
expression O
of O
HULC B-RNA
was O
upregulated O
in O
cervical B-Disease
cancer I-Disease
, O
and O
associated O
with O
overall O
survival O
, O
indicating O
that O
HULC B-RNA
may O
serve O
as O
a O
predictive O
biomarker O
for O
the O
prognosis O
of O
cervical B-Disease
cancer I-Disease
. O

The O
data O
demonstrated O
that O
SNHG1 B-RNA
functioned O
as O
an O
oncogene O
in O
colon B-Disease
cancer I-Disease
and O
may O
act O
via O
the O
Wnt O
/ O
β O
- O
catenin O
pathway O
to O
promote O
carcinogenesis O
. O

Thanks O
to O
the O
high O
stability O
, O
tissue O
and O
plasma O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
181 I-RNA
may O
be O
a O
novel O
biomarker O
for O
the O
diagnosis O
of O
gastric B-Disease
cancer I-Disease
. O

Taken O
together O
, O
these O
findings O
revealed O
that O
MALAT1 O
knockdown O
enhanced O
cytotoxicity O
of O
CDDP O
in O
ovarian B-Disease
cancer I-Disease
cells O
in O
vivo O
. O

Studies O
have O
shown O
the O
high O
expression O
pattern O
and O
oncogenic O
role O
of O
CCAT1 B-RNA
in O
different O
types O
of O
cancer B-Disease
, O
and O
aberrant O
expression O
of O
CCAT1 B-RNA
is O
involved O
in O
several O
processes O
correlated O
with O
carcinogenesis O
such O
as O
cell O
proliferation O
, O
apoptosis O
, O
migration O
and O
invasion O
by O
regulating O
different O
target O
genes O
and O
pathways O
. O

SNORD89 B-RNA
deteriorates O
the O
prognosis O
of O
ovarian B-Disease
cancer I-Disease
patients O
by O
regulating O
Notch1 O
- O
c O
- O
Myc O
pathway O
to O
promote O
cell O
stemness O
and O
acts O
as O
an O
oncogene O
in O
ovarian O
tumorigenesis O
. O

SNORD114 B-RNA
- I-RNA
10 I-RNA
was O
downregulated O
in O
metastatic O
omentum O
tissues O
, O
suggesting O
that O
this O
snoR O
may O
provide O
a O
prediagnostic O
biomarker O
for O
ovarian B-Disease
cancer I-Disease
metastasis O
( O
72 O
) O
. O

SNHG6 B-RNA
is O
upregulated O
in O
primary O
breast O
cancers O
and O
promotes O
cell O
cycle O
progression O
in O
breast B-Disease
cancer I-Disease
- O
derived O
cell O
lines O
. O

Small O
nucleolar O
R O
host O
gene O
16 O
( O
SNHG16 B-RNA
) O
and O
autophagy O
- O
related O
4B O
( O
ATG4B O
) O
were O
significantly O
upregulated O
in O
osteosarcoma B-Disease
tissues O
than O
the O
normal O
ones O
, O
and O
the O
higher O
expression O
level O
of O
SNHG16 B-RNA
predicted O
a O
poor O
prognosis O
in O
osteosarcoma B-Disease
patients O
. O

RPPH1 B-RNA
functions O
as O
a O
tumour O
promoter O
and O
plays O
an O
important O
role O
in O
advancing O
tumorigenesis O
by O
targeting O
miR B-RNA
- I-RNA
122 I-RNA
and O
may O
serve O
as O
a O
novel O
and O
potential O
therapeutic O
, O
diagnostic O
or O
prognostic O
target O
in O
breast B-Disease
cancer I-Disease
. O

Results O
revealed O
that O
LINC00958 B-RNA
was O
significantly O
upregulated O
in O
glioma B-Disease
tissues O
and O
cell O
lines O
compared O
with O
that O
of O
adjacent O
normal O
brain O
tissues O
and O
normal O
human O
astrocytes O
. O

Reduced O
expression O
of O
circRNA O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
3159 I-RNA
in O
gastric B-Disease
cancer I-Disease
and O
its O
clinical O
significance O
. O

QRT O
- O
PCR O
showed O
that O
circRNA B-RNA
_ I-RNA
102231 I-RNA
expression O
was O
significantly O
upregulated O
in O
LAC O
tissues O
and O
associated O
with O
the O
advanced O
TNM O
stage O
, O
lymph O
node O
metastasis O
, O
and O
poor O
overall O
survival O
of O
lung B-Disease
cancer I-Disease
patients O
. O

PAX8 B-RNA
- I-RNA
AS1 I-RNA
- I-RNA
N I-RNA
was O
down O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
and O
reduced O
expression O
of O
PAX8 B-RNA
- I-RNA
AS1 I-RNA
- I-RNA
N I-RNA
indicated O
poor O
survival O
of O
breast B-Disease
cancer I-Disease
patients O
. O

overexpression O
of O
RBMS3 B-RNA
- I-RNA
AS3 I-RNA
was O
found O
to O
suppress O
cell O
proliferation O
, O
migration O
, O
invasion O
, O
and O
angiogenesis O
as O
well O
as O
the O
tumorigenic O
ability O
of O
prostate B-Disease
cancer I-Disease
. O

Overexpression O
of O
Long O
Non O
- O
Coding O
RNA O
TUG1 B-RNA
Promotes O
Colon O
Cancer O
Progression O
. O

Overexpression O
of O
LINC00346 B-RNA
significantly O
enhanced O
the O
proliferation O
, O
colony O
formation O
, O
and O
tumorigenesis O
of O
pancreatic B-Disease
cancer I-Disease
cells O
. O

Overexpression O
of O
CASC8 B-RNA
remarkably O
suppressed O
the O
bladder B-Disease
cancer I-Disease
cell O
proliferation O
. O

Overall O
, O
these O
results O
demonstrate O
that O
lncRNA O
pancEts B-RNA
- I-RNA
1 I-RNA
exhibitsoncogenic O
properties O
that O
drive O
the O
progression O
of O
gastric B-Disease
cancer I-Disease
via O
regulating O
the O
NONO O
/ O
ERG O
/ O
Ets O
- O
1 O
axis O
. O

Our O
study O
demonstrated O
that O
lncRNA O
- O
ATB O
expression O
was O
partly O
decreased O
in O
gastric B-Disease
cancer I-Disease
and O
inversely O
correlated O
with O
the O
depth O
of O
invasion O
( O
T O
) O
. O

Our O
results O
showed O
that O
upregulation O
of O
lncRNA O
- O
UCA1 B-RNA
in O
glioma B-Disease
tissues O
and O
cell O
lines O
could O
promote O
glioma B-Disease
cell O
proliferation O
and O
migration O
through O
interaction O
with O
miR B-RNA
- I-RNA
182 I-RNA
, O
and O
knockdown O
of O
UCA1 B-RNA
inhibited O
the O
proliferation O
and O
migration O
of O
human O
glioma B-Disease
cell O
. O

Our O
results O
showed O
that O
CCAT2 B-RNA
functioning O
as O
a O
potential O
oncogene O
was O
upregulated O
in O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Our O
results O
pointed O
out O
that O
lncRNA O
DUXAP8 B-RNA
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
tissues O
, O
which O
can O
promote O
the O
progression O
of O
bladder B-Disease
cancer I-Disease
through O
inhibiting O
PTEN O
. O

Our O
results O
demonstrated O
that O
GHET1 B-RNA
was O
up O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
, O
and O
promoted O
breast B-Disease
cancer I-Disease
cell O
proliferation O
, O
invasion O
and O
migration O
by O
affecting O
EMT O
. O

Our O
results O
delineated O
a O
novel O
mechanism O
of O
lincRNA B-RNA
- I-RNA
p21 I-RNA
in O
enhancing O
hypoxic O
tumor O
cell O
radiosensitivity O
, O
which O
might O
provide O
valuable O
targets O
for O
radiation O
therapy O
for O
solid O
tumors O
, O
such O
as O
hepatoma B-Disease
and O
glioma B-Disease
. O

Our O
preliminary O
study O
had O
found O
that O
cir B-RNA
- I-RNA
GLI2 I-RNA
was O
significantly O
upregulated O
in O
osteosarcoma B-Disease
tissues O
compared O
to O
adjacent O
non O
- O
tumor O
tissue O
. O

Our O
findings O
offer O
a O
mechanistic O
explanation O
of O
lncRNA O
H19 B-RNA
' O
s O
role O
in O
the O
pathogenesis O
of O
diabetic B-Disease
hyperglycemia I-Disease
and O
suggest O
that O
targeting O
hepatic O
H19 B-RNA
may O
hold O
the O
potential O
of O
new O
treatment O
for O
this O
disease O
. O

Our O
earlier O
work O
showed O
that O
expression O
of O
long O
noncoding O
RNA O
- O
growth O
arrest O
- O
specific O
5 O
( O
lncRNA O
GAS5 B-RNA
) O
was O
significantly O
increased O
in O
the O
plaque O
of O
atherosclerosis B-Disease
collected O
from O
patients O
and O
animal O
models O
. O

Our O
data O
showed O
that O
the O
expression O
of O
XIST B-RNA
was O
significantly O
up O
- O
regulated O
in O
glioma B-Disease
tissues O
and O
enhanced O
the O
proliferation O
of O
glioma B-Disease
cells O
. O

Our O
data O
revealed O
that O
MALAT1 B-RNA
inhibited O
tongue B-Disease
cancer I-Disease
cell O
growth O
and O
metastasis O
through O
miR B-RNA
- I-RNA
124 I-RNA
- O
dependent O
JAG1 O
regulation O
. O

Our O
analysis O
revealed O
that O
the O
expression O
levels O
of O
FOXCUT B-RNA
and O
FOXC1 O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
tissues O
were O
significantly O
higher O
than O
those O
observed O
in O
chronic O
nasopharyngitis O
tissues O
and O
that O
FOXCUT B-RNA
expression O
was O
positively O
correlated O
with O
FOXC1 O
expression O
. O

OIP5 B-RNA
- I-RNA
AS1 I-RNA
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
, O
and O
associated O
with O
clinical O
progression O
and O
short O
overall O
survival O
. O

Not O
surprisingly O
, O
in O
vitro O
functional O
experiments O
also O
demonstrated O
that O
the O
overexpression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
77837 I-RNA
and O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
4826 I-RNA
significantly O
weakened O
the O
proliferation O
, O
migration O
, O
and O
invasion O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

NORAD B-RNA
is O
downregulated O
in O
lung O
and O
breast O
cancers O
, O
and O
its O
low O
expression O
correlates O
with O
metastasis O
and O
adverse O
prognosis O

NEAT1 B-RNA
upregulate O
IGF2 B-RNA
expression O
through O
absorbing O
miR B-RNA
- I-RNA
185 I-RNA
- I-RNA
5p I-RNA
to O
enhances O
the O
migration O
and O
invasion O
of O
colon B-Disease
cancer I-Disease
cells O
. O

NBR2 B-RNA
is O
downregulated O
and O
its O
low O
expression O
correlates O
with O
poor O
clinical O
outcomes O
in O
some O
human O
cancers O
. O

Moreover O
, O
dysregulated O
cZNF609 B-RNA
expression O
was O
detected O
in O
the O
clinical O
samples O
of O
the O
patients O
with O
diabetes B-Disease
, O
hypertension B-Disease
, O
and O
coronary B-Disease
artery I-Disease
disease I-Disease
. O

More O
recently O
, O
additional O
GWAS O
identified O
ANRIL B-RNA
as O
a O
risk O
locus O
for O
several O
cancers O
including O
breast O
cancer O
, O
nasopharyngeal B-Disease
carcinoma I-Disease
, O
basal B-Disease
cell I-Disease
carcinoma I-Disease
, O
and O
glioma B-Disease
. O

Microdeletions O
in O
the O
human O
H19 B-RNA
DMR O
result O
in O
loss O
of O
IGF2 O
imprinting O
and O
Beckwith O
- O
Wiedemann O
syndrome O
. O

m6A O
- O
induced O
lncRNA O
RP11 B-RNA
triggers O
the O
dissemination O
of O
colorectal B-Disease
cancer I-Disease
cells O
via O
upregulation O
of O
Zeb1 O
. O

Low O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
6633 I-RNA
in O
human O
gastric B-Disease
cancer I-Disease
and O
its O
clinical O
significances O
. O

Loss O
- O
of O
- O
function O
assay O
indicated O
that O
linc B-RNA
- I-RNA
UFC1 I-RNA
exerted O
as O
an O
oncogene O
because O
it O
promoted O
the O
growth O
and O
metastasis O
of O
cervical B-Disease
cancer I-Disease
cells O
in O
vitro O
and O
in O
vivo O
. O

Long O
non O
- O
coding O
RNA O
TUG1 B-RNA
regulates O
ovarian B-Disease
cancer I-Disease
proliferation O
and O
metastasis O
via O
affecting O
epithelial O
- O
mesenchymal O
transition O
. O

Long O
Noncoding O
RNA O
PVT1 B-RNA
Promotes O
Melanoma O
Progression O
via O
Endogenous O
Sponging O
miR B-RNA
- I-RNA
26b I-RNA

Long O
Noncoding O
RNA O
Malat1 O
Regulates O
Cerebrovascular O
Pathologies O
in O
Ischemic O
Stroke O
. O

Long O
noncoding O
RNA O
MALAT1 B-RNA
promotes O
uveal B-Disease
melanoma I-Disease
cell O
growth O
and O
invasion O
by O
silencing O
of O
miR B-RNA
- I-RNA
140 I-RNA
. O

Long O
non O
- O
coding O
RNA O
Linc O
- O
ITGB1 B-RNA
knockdown O
inhibits O
cell O
migration O
and O
invasion O
in O
GBC O
- O
SD O
/ O
M O
and O
GBC O
- O
SD O
gallbladder B-Disease
cancer I-Disease
cell O
lines O
. O

Long O
non O
- O
coding O
RNA O
LINC00222 B-RNA
regulates O
GSK3beta O
activity O
and O
promotes O
cell O
apoptosis O
in O
lung B-Disease
adenocarcinoma I-Disease
; O
overexpression O
of O
LINC00222 B-RNA
enhanced O
the O
activity O
of O
glycogen O
synthase O
kinase O
- O
3beta O
( O
GSK3beta O
) O
, O
which O
is O
a O
key O
element O
of O
the O
Wnt O
signaling O
pathway O
; O
Enforced O
expression O
of O
LINC00222 B-RNA
significantly O
inhibited O
the O
proliferation O
, O
migration O
and O
invasive O
ability O
of O
lung B-Disease
adenocarcinoma I-Disease
cells O

Long O
non O
- O
coding O
RNA O
HULC B-RNA
interacts O
with O
miR B-RNA
- I-RNA
613 I-RNA
to O
regulate O
colon B-Disease
cancer I-Disease
growth O
and O
metastasis O
through O
targeting O
RTKN O
. O

Long O
noncoding O
RNA O
GAS5 B-RNA
suppresses O
triple B-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
progression O
through O
inhibition O
of O
proliferation O
and O
invasion O
by O
competitively O
binding O
miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
5p I-RNA
; O
GAS5 B-RNA
can O
bind O
to O
miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
5p I-RNA
and O
there O
is O
a O
negative O
relationship O
between O
GAS5 B-RNA
and O
miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
5p I-RNA
expression O
; O
GAS5 B-RNA
functioned O
as O
a O
competing O
endogenous O
RNA O
( O
ceRNA O
) O
antagonizing O
tumor O
promotion O
of O
miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
5p I-RNA
- O
expressing O
TNBC O
cells O

Long O
Noncoding O
RNA O
EGFR B-RNA
- I-RNA
AS1 I-RNA
Promotes O
Cell O
Proliferation O
by O
Increasing O
EGFR O
mRNA O
Stability O
in O
Gastric O
Cancer O
. O

Long O
noncoding O
RNA O
CPS1 B-RNA
- I-RNA
IT1 I-RNA
suppresses O
cell O
proliferation O
and O
metastasis O
in O
human O
lung B-Disease
cancer I-Disease
. O

Long O
noncoding O
RNA O
CCDC26 B-RNA
as O
a O
potential O
predictor O
biomarker O
contributes O
to O
tumorigenesis O
in O
pancreatic B-Disease
cancer I-Disease

Long O
Noncoding O
RNA O
CCAT2 B-RNA
Knockdown O
Suppresses O
Tumorous O
Progression O
by O
Sponging O
miR B-RNA
- I-RNA
424 I-RNA
in O
Epithelial O
Ovarian O
Cancer O
. O

Long O
Noncoding O
RNA O
BCYRN1 B-RNA
Promotes O
the O
proliferation O
of O
Colorectal O
Cancer O
Cells O
via O
Up O
- O
Regulating O
NPR3 O
Expression O

Lnc O
- O
THOR O
depletion O
inhibits O
human O
glioma B-Disease
cell O
survival O
possibly O
by O
activating O
MAGEA6 O
- O
AMPK O
signaling O
. O

LncRNA O
- O
SNHG7 B-RNA
promotes O
the O
proliferation O
, O
migration O
and O
invasion O
and O
inhibits O
apoptosis O
of O
lung B-Disease
cancer I-Disease
cells O
by O
enhancing O
the O
FAIM2 O
expression O
. O

LncRNA O
- O
SNHG1 B-RNA
contributes O
to O
gastric B-Disease
cancer I-Disease
cell O
proliferation O
by O
regulating O
DNMT1 O
; O
LncRNA O
- O
SNHG1 B-RNA
accelerated O
the O
proliferation O
of O
gastric B-Disease
cancer I-Disease
cells O
obviously O
and O
increased O
the O
expression O
of O
DNMT1 O

lncRNA B-RNA
- I-RNA
ATB I-RNA
downregulation O
can O
inhibit O
ovarian B-Disease
cancer I-Disease
cell O
proliferation O
, O
invasion O
and O
migration O
, O
and O
promote O
cell O
apoptosis O
. O

LncRNA O
ZFAS1 B-RNA
promotes O
cell O
migration O
and O
invasion O
of O
fibroblast O
- O
like O
synoviocytes O
by O
suppression O
of O
miR B-RNA
- I-RNA
27a I-RNA
in O
rheumatoid B-Disease
arthritis I-Disease
. O

lncRNA O
TP73 B-RNA
- I-RNA
AS1 I-RNA
regulated O
cell O
metastasis O
through O
inducing O
the O
activation O
of O
Wnt O
/ O
β O
- O
catenin O
signaling O
pathway O
in O
lung B-Disease
adenocarcinoma I-Disease
. O

LncRNA O
TINCR B-RNA
is O
associated O
with O
clinical O
progression O
and O
serves O
as O
tumor O
suppressive O
role O
in O
prostate B-Disease
cancer I-Disease
. O
TINCR B-RNA
plays O
a O
tumor O
suppressive O
role O
in O
regulating O
prostate B-Disease
cancer I-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
through O
modulating O
TRIP13 O
expression O

LncRNA O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
may O
be O
a O
novel O
molecule O
involved O
in O
cervical B-Disease
cancer I-Disease
progression O
, O
which O
may O
be O
of O
use O
as O
both O
a O
potential O
predictor O
and O
therapeutic O
target O
. O

LncRNA O
SNHG16 B-RNA
promotes O
tumor O
growth O
of O
pancreatic B-Disease
cancer I-Disease
by O
targeting O
miR B-RNA
- I-RNA
218 I-RNA
- I-RNA
5p I-RNA
, O
SNHG16 B-RNA
is O
up O
- O
regulated O
in O
human O
PC O
and O
is O
associated O
with O
poor O
survival O
. O
( O

LncRNA O
SNHG1 B-RNA
can O
depend O
on O
the O
Notch1 O
pathway O
to O
suppress O
the O
proliferation O
of O
gastric B-Disease
cancer I-Disease
cells O
and O
promote O
their O
apoptosis O
. O

LncRNA O
RSU1P2 B-RNA
contributes O
to O
tumorigenesis O
by O
acting O
as O
a O
ceRNA O
against O
let O
- O
7a O
in O
cervical B-Disease
cancer I-Disease
cells O
. O

LncRNA O
RAB5IF B-RNA
promotes O
the O
growth O
of O
hepatocellular B-Disease
carcinoma I-Disease
cells O
via O
LGR5 O
mediated O
β O
- O
catenin O
and O
c O
- O
Myc O
signaling O
as O
a O
potent O
oncogenic O
target O
. O

LncRNA O
PVT1 B-RNA
Regulates O
Chondrocyte O
Apoptosis O
in O
Osteoarthritis O
by O
Acting O
as O
a O
Sponge O
for O
miR B-RNA
- I-RNA
488 I-RNA
- I-RNA
3p I-RNA

LncRNA O
PVT1 B-RNA
promotes O
the O
growth O
HPV O
positive O
and O
negative O
cervical B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
by O
inhibiting O
TGF O
- O
β O
1 O
. O

LncRNA O
NORAD B-RNA
was O
highly O
expressed O
in O
ovarian B-Disease
cancer I-Disease
tissues O
, O
while O
silencing O
lncRNA O
NORAD B-RNA
expression O
could O
inhibit O
the O
proliferation O
, O
invasion O
, O
migration O
, O
and O
EMT O
of O
ovarian B-Disease
cancer I-Disease
cells O
by O
regulating O
miR B-RNA
- I-RNA
199a I-RNA
- I-RNA
3p I-RNA

LncRNA O
NEF B-RNA
is O
downregulated O
in O
triple O
negative O
breast B-Disease
cancer I-Disease
and O
correlated O
with O
poor O
prognosis O
. O

LncRNA O
MORT B-RNA
Inhibits O
Cancer O
Cell O
Proliferation O
and O
Promotes O
Apoptosis O
in O
Mantle O
Cell O
Lymphoma O
by O
Upregulating O
miRNA B-RNA
- I-RNA
16 I-RNA

lncRNA O
MEG3 B-RNA
Suppresses O
the O
Tumorigenesis O
of O
Hemangioma O
by O
Sponging O
miR B-RNA
- I-RNA
494 I-RNA
and O
Regulating O
PTEN O
/ O
PI3K O
/ O
AKT O
Pathway O
. O

lncRNA O
LUCRC B-RNA
( O
LncRNA O
Upregulated O
in O
Colorectal O
Cancer O
) O
is O
highly O
expressed O
in O
colorectal O
tumor O
samples O
and O
is O
required O
for O
colorectal B-Disease
cancer I-Disease
cell O
proliferation O
, O
migration O
, O
and O
invasion O
in O
cultured O
cells O
and O
tumorigenesis O
in O
xenografts O
. O

LncRNA O
ITGB2 B-RNA
- I-RNA
AS1 I-RNA
Could O
Promote O
the O
Migration O
and O
invasion O
of O
Breast O
Cancer O
Cells O
through O
Up O
regulating O
ITGB2 O

lncRNA O
GAS5 B-RNA
- I-RNA
AS1 I-RNA
inhibited O
glioma B-Disease
proliferation O
, O
migration O
, O
and O
invasion O
by O
sponging O
miR B-RNA
- I-RNA
106b I-RNA
- I-RNA
5p I-RNA
and O
regulating O
the O
expression O
of O
TUSC2 O

lncRNA O
Ftx B-RNA
promotes O
aerobic O
glycolysis O
and O
tumor O
progression O
through O
the O
PPARgamma O
pathway O
in O
hepatocellular B-Disease
carcinoma I-Disease
; O
peroxisome O
proliferator O
- O
activated O
receptor O
gamma O
( O
PPARgamma O
) O
expression O
in O
human O
HCC O
tissues O
and O
cell O
lines O
was O
positively O
correlated O
with O
lncRNA O
Ftx B-RNA

LncRNA O
FOXD2 B-RNA
- I-RNA
AS1 I-RNA
was O
overexpressed O
in O
human O
glioma B-Disease
, O
and O
upregulated O
FOXD2 O
- O
AS11 O
expression O
indicated O
higher O
WHO O
grade O

lncRNA O
DLG1 B-RNA
- I-RNA
AS1 I-RNA
Promotes O
Cell O
proliferation O
by O
Competitively O
Binding O
with O
miR B-RNA
- I-RNA
107 I-RNA
and O
Up O
- O
Regulating O
ZHX1 O
Expression O
in O
Cervical O
Cancer O
. O

LncRNA O
DANCR B-RNA
Promotes O
Lung O
Cancer O
by O
Sequestering O
miR B-RNA
- I-RNA
216a I-RNA
; O
The O
miR B-RNA
- I-RNA
216a I-RNA
level O
in O
cancer O
cells O
was O
negatively O
correlated O
with O
DANCR B-RNA
expression O
; O
DANCR B-RNA
upregulation O
is O
a O
potential O
indicator O
of O
aggressive O
lung B-Disease
cancer I-Disease

LncRNA O
CPS1 B-RNA
- I-RNA
IT1 I-RNA
suppresses O
EMT O
and O
metastasis O
of O
colorectal B-Disease
cancer I-Disease
by O
inhibiting O
hypoxia O
- O
induced O
autophagy O
through O
inactivation O
of O
HIF O
- O
1alpha O
; O
CPS1 B-RNA
- I-RNA
IT1 I-RNA
suppresses O
EMT O
and O
autophagy O
by O
inhibiting O
the O
activation O
of O
HIF O
- O
1alpha O
in O
CRC O

LncRNA O
CASC2 B-RNA
inhibited O
the O
viability O
and O
induced O
the O
apoptosis O
of O
hepatocellular B-Disease
carcinoma I-Disease
cells O
through O
regulating O
miR B-RNA
- I-RNA
24 I-RNA
- I-RNA
3p I-RNA
; O
the O
expression O
of O
CASC2 B-RNA
was O
negatively O
related O
to O
miR B-RNA
- I-RNA
24 I-RNA
- I-RNA
3p I-RNA
expression O
in O
the O
HCC O
tissues O
; O
CASC2 B-RNA
could O
negatively O
regulate O
the O
expression O
of O
miR B-RNA
- I-RNA
24 I-RNA
- I-RNA
3p I-RNA
in O
vitro O

lncR O
SNHG20 B-RNA
plays O
an O
pivotal O
role O
in O
ovarian B-Disease
cancer I-Disease
progression O
by O
regulating O
Wnt O
/ O
β O
- O
catenin O
sigling O
. O

LncR O
SNHG14 B-RNA
was O
highly O
expressed O
in O
cervical O
tumor O
tissues O
or O
cells O
, O
which O
could O
promote O
the O
progression O
of O
cervical B-Disease
cancer I-Disease
. O

LINK B-RNA
- I-RNA
A I-RNA
lncRNA O
is O
upregulated O
in O
osteosarcoma B-Disease
and O
may O
regulate O
migration O
, O
invasion O
and O
stemness O
of O
osteosarcoma B-Disease
cells O
through O
TGF O
- O
β O
1 O
. O

LINC O
- O
ROR O
up O
- O
regulation O
may O
have O
a O
role O
in O
glioblastoma B-Disease
tumorigenesis O
and O
could O
be O
a O
potential O
prognostic O
marker O
for O
this O
fatal O
disease O
. O

Linc B-RNA
- I-RNA
ROR I-RNA
is O
upregulated O
in O
breast O
tumor O
tissues O
. O
Linc B-RNA
- I-RNA
ROR I-RNA
promotes O
the O
proliferation O
, O
migration O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O

LincRNA O
- O
p21 O
was O
found O
to O
be O
down O
- O
regulated O
in O
human O
prostate B-Disease
cancer I-Disease
, O
and O
low O
levels O
of O
lincRNA B-RNA
- I-RNA
p21 I-RNA
correlated O
with O
high O
disease O
stage O
and O
prediction O
of O
poor O
survival O
. O

linc O
- O
OIP5 O
in O
MDA O
- O
MB O
- O
231 O
breast B-Disease
cancer I-Disease
cells O
may O
act O
on O
the O
upstream O
of O
the O
YAP1 O
/ O
Notch O
/ O
NRP1 O
signaling O
circuit O
to O
affect O
proliferation O
, O
migration O
, O
and O
tube O
formation O
of O
co O
- O
cultured O
HUVECs O
in O
a O
non O
- O
cellular O
direct O
contact O
way O
through O
JAG1 O
in O
conditioned O
medium O
. O

LINC01127 B-RNA
expression O
in O
ovarian B-Disease
cancer I-Disease
tissues O
was O
significantly O
higher O
than O
that O
in O
normal O
ovary O
tissues O
. O

LINC00662 B-RNA
participated O
in O
the O
malignant O
progression O
of O
chordoma B-Disease
by O
the O
promotion O
of O
RNF144B O
by O
acting O
as O
a O
sponge O
of O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
5p I-RNA
, O
suggesting O
that O
LINC00662 B-RNA
was O
a O
promising O
therapeutic O
target O
for O
chordoma B-Disease
. O

LINC00339 B-RNA
was O
overexpressed O
in O
ovarian B-Disease
cancer I-Disease
tissues O
, O
showed O
a O
poor O
prognosis O
in O
patients O
with O
ovarian B-Disease
cancer I-Disease
, O
and O
correlated O
with O
tumor O
size O
and O
advanced O
clinical O
stages O
. O

LINC00273 B-RNA
promoted O
TGF O
β O
- O
induced O
lung B-Disease
cancer I-Disease
EMT O
through O
miR B-RNA
- I-RNA
200a I-RNA
- I-RNA
3p I-RNA
/ O
ZEB1 B-RNA
feedback O
loop O
and O
may O
serve O
as O
a O
potential O
target O
for O
therapeutic O
intervention O
in O
lung B-Disease
cancer I-Disease
metastasis O
. O

Linc00152 O
was O
overexpressed O
in O
the O
proliferating O
- O
phase O
hemangioma B-Disease
tissues O
when O
compared O
with O
that O
in O
involuting O
- O
phase O
. O

LEF1 B-RNA
- I-RNA
AS1 I-RNA
upregulation O
in O
lung B-Disease
cancer I-Disease
is O
associated O
with O
the O
poor O
survival O
of O
patients O

Knock O
- O
down O
of O
ZEB1 B-RNA
inhibits O
the O
proliferation O
, O
invasion O
and O
migration O
of O
gastric B-Disease
cancer I-Disease
cells O
. O

Conclusion O
Knock O
- O
down O
of O
ZEB1 B-RNA
expression O
by O
RNA O
interference O
can O
decease O
lncRNA O
HOTAIR B-RNA
expression O
and O
restrain O
cell O
proliferation O
, O
invasion O
and O
migration O
in O
gastric B-Disease
cancer I-Disease
BGC823 O
cells O

Knockdown O
of O
long O
non O
- O
coding O
RNA O
TP73 B-RNA
- I-RNA
AS1 I-RNA
inhibits O
osteosarcoma B-Disease
cell O
proliferation O
and O
invasion O
through O
sponging O
miR B-RNA
- I-RNA
142 I-RNA
. O

It O
was O
demonstrated O
that O
lncRNA O
- O
MEG3 O
expression O
was O
downregulated O
in O
gastric B-Disease
carcinoma I-Disease
cells O
compared O
with O
normal O
gastric O
cells O
. O

It O
turns O
out O
that O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
is O
upregulated O
in O
colorectal B-Disease
cancer I-Disease
tissues O
and O
its O
expression O
is O
significantly O
associated O
with O
overall O
survival O
rate O
and O
recurrence O
- O
free O
survival O
. O

Increased O
expression O
of O
long O
non O
- O
coding O
RNA O
XIST B-RNA
predicts O
favorable O
prognosis O
of O
cervical B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
subsequent O
to O
definitive O
chemoradiation O
therapy O
. O

Increased O
Expression O
of O
Exosomal O
AGAP2 B-RNA
- I-RNA
AS1 I-RNA
( O
AGAP2 O
Antisense O
RNA O
1 O
) O
In O
Breast O
Cancer O
Cells O
Inhibits O
Trastuzumab O
- O
Induced O
Cell O
Cytotoxicity O
. O

In O
vitro O
experiments O
further O
demonstrated O
that O
overexpressed O
CASC2 B-RNA
decreased O
hepatocellular B-Disease
carcinoma I-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
as O
well O
as O
promoted O
apoptosis O
via O
inactivating O
the O
mitogen O
- O
activated O
protein O
kinase O
signalling O
pathway O
. O

In O
this O
study O
, O
we O
report O
that O
FGF13 B-RNA
- I-RNA
AS1 I-RNA
expression O
is O
decreased O
in O
breast B-Disease
cancer I-Disease
tissue O
compared O
with O
corresponding O
normal O
tissue O
, O
and O
the O
downregulation O
of O
FGF13 B-RNA
- I-RNA
AS1 I-RNA
is O
associated O
with O
poor O
prognosis O
. O

In O
this O
study O
, O
we O
found O
that O
the O
LINC01133 B-RNA
expression O
was O
significantly O
down O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
samples O
and O
was O
associated O
with O
progression O
and O
poor O
prognosis O
of O
breast B-Disease
cancer I-Disease
. O

In O
this O
study O
, O
we O
found O
that O
the O
expression O
of O
the O
lncRNA O
linc00460 O
is O
significantly O
upregulated O
in O
NSCLC O
tumors O
and O
associated O
with O
poor O
prognosis O
for O
NSCLC O
patients O
, O
implying O
that O
linc00460 O
is O
important O
for O
lung B-Disease
cancer I-Disease
development O
. O

In O
this O
study O
, O
we O
found O
that O
LncRNA O
- O
ZEB2 B-RNA
- I-RNA
AS1 I-RNA
was O
dramatically O
up O
- O
regulated O
in O
our O
breast B-Disease
cancer I-Disease
specimens O
and O
cells O
( O
MDA231 O
) O
, O

In O
this O
study O
, O
we O
found O
that O
lncRNA O
CCAT2 B-RNA
was O
overexpressed O
in O
glioma B-Disease
tissues O
and O
cell O
lines O
and O
associated O
with O
tumor O
grade O
and O
size O
. O

In O
this O
study O
, O
we O
found O
that O
a O
novel O
lncRNA O
Zinc O
finger O
E O
- O
box O
- O
binding O
homeebox1 O
( O
ZEB1 O
) O
antisense O
RNA O
( O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
) O
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
to O
paired O
noncancerous O
tissues O
. O

In O
this O
study O
, O
we O
found O
HOXB B-RNA
- I-RNA
AS1 I-RNA
was O
highly O
expressed O
in O
human O
glioblastoma B-Disease
tissues O
and O
cell O
lines O
, O
and O
was O
associated O
with O
survival O
time O
of O
patients O
. O

In O
this O
study O
, O
we O
firstly O
found O
that O
UCA1 B-RNA
was O
upregulated O
in O
glioma B-Disease
tumor O
samples O
and O
negatively O
correlated O
with O
survival O
time O
. O

In O
this O
study O
, O
we O
demonstrated O
that O
the O
lncRNA O
FAM83H B-RNA
- I-RNA
AS1 I-RNA
( O
also O
known O
as O
onco B-RNA
- I-RNA
lncRNA I-RNA
- I-RNA
3 I-RNA
) O
is O
up O
- O
regulated O
in O
primary O
keratinocytes O
expressing O
HPV O
- O
16 O
oncogene O
E6 O
as O
well O
as O
HPV O
- O
16 O
positive O
human O
cervical B-Disease
cancer I-Disease
cell O
lines O
and O
cervical O
tumor O
samples O
. O

In O
this O
study O
, O
to O
identify O
cancer O
- O
related O
lncRNAs O
and O
genes O
, O
we O
screened O
for O
those O
lncRNAs O
that O
were O
differentially O
expressed O
in O
lung B-Disease
adenocarcinoma I-Disease
, O
which O
revealed O
LINC00628 B-RNA
overexpression O
and O
low O
expression O
of O
laminin O
subunit O
alpha O
3 O
( O
LAMA3 O
) O
. O

In O
this O
study O
, O
the O
expression O
of O
lncRNA O
HOTAIR B-RNA
was O
measured O
by O
qRT O
- O
PCR O
, O
and O
HOTAIR B-RNA
expression O
was O
found O
to O
be O
significantly O
upregulated O
in O
human O
retinoblastomas O
tissues O
as O
compared O
with O
that O
in O
paracancerous O
tissues O
. O

In O
this O
study O
we O
showed O
that O
plasma O
lncRNA O
CASC11 B-RNA
was O
upregulated O
, O
while O
plasma O
miRNA B-RNA
- I-RNA
150 I-RNA
was O
downregulated O
in O
patients O
with O
early O
- O
stage O
bladder B-Disease
cancer I-Disease
than O
in O
healthy O
controls O
. O

In O
this O
study O
we O
found O
that O
PTCSC3 B-RNA
was O
downregulated O
, O
while O
toll O
- O
like O
receptor O
4 O
( O
TLR4 O
) O
was O
upregulated O
in O
periodontal O
ligament O
stem O
cells O
( O
PDLSCs O
) O
isolated O
from O
periodontitis B-Disease
affected O
teeth O
that O
in O
PDLSCs O
isolated O
from O
healthy O
teeth O
. O

In O
this O
article O
, O
by O
means O
of O
qRT O
- O
PCR O
assay O
, O
we O
found O
that O
OR3A4 B-RNA
was O
over O
- O
expressed O
in O
human O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
and O
associated O
with O
clinicopathological O
characteristics O
. O

In O
the O
present O
study O
, O
we O
found O
that O
the O
long O
intergenic O
non O
- O
coding O
RNA O
linc O
- O
DYNC2H1 O
- O
4 O
was O
upregulated O
in O
pancreatic B-Disease
cancer I-Disease
cell O
line O
BxPC O
- O
3 O
- O
Gem O
with O
acquired O
gemcitabine O
resistance O
. O

In O
the O
present O
study O
, O
we O
found O
that O
SNHG7 B-RNA
expression O
was O
significantly O
upregulated O
in O
hepatic B-Disease
carcinoma I-Disease
tissues O
, O
especially O
in O
aggressive O
cases O
, O
and O
it O
was O
closely O
correlated O
with O
the O
poor O
prognosis O
. O

In O
the O
present O
study O
, O
we O
found O
that O
PCAT B-RNA
- I-RNA
1 I-RNA
was O
increased O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
. O

In O
the O
present O
study O
, O
we O
found O
that O
HOXA B-RNA
- I-RNA
AS2 I-RNA
was O
up O
- O
regulated O
in O
human O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
and O
associated O
with O
clinicopathological O
characteristics O
. O

In O
the O
present O
study O
, O
the O
regulatory O
model O
of O
the O
lncRNA O
placenta O
- O
specific O
protein O
2 O
( O
PLAC2 B-RNA
) O
upregulation O
in O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
( O
OSCC O
) O
was O
investigated O
and O
its O
biological O
functions O
in O
OSCC O
malignant O
progression O
was O
identified O
. O

In O
the O
present O
study O
, O
lncRNA O
- O
MALAT1 B-RNA
was O
specifically O
upregulated O
in O
tongue B-Disease
cancer I-Disease
cell O
lines O
and O
overexpression O
promoted O
tongue B-Disease
cancer I-Disease
cell O
growth O
by O
targeting O
miR O
- O
124 O
. O

In O
the O
clinical O
validation O
cohort O
, O
our O
results O
showed O
GLIDR B-RNA
was O
significantly O
up O
- O
regulated O
in O
prostate B-Disease
cancer I-Disease
samples O
and O
cell O
lines O
. O

In O
summary O
, O
these O
results O
suggested O
that O
SNHG1 B-RNA
promoted O
tumor O
growth O
of O
colorectal B-Disease
cancer I-Disease
. O

In O
summary O
, O
our O
study O
demonstrate O
that O
Adam12 O
and O
lnc015192 B-RNA
promote O
breast B-Disease
cancer I-Disease
metastasis O
partly O
by O
sponging O
miR B-RNA
- I-RNA
34a I-RNA
through O
the O
ceRNA O
mechanism O
. O

In O
recent O
years O
, O
a O
growing O
number O
of O
studies O
have O
shown O
that O
UCA1 B-RNA
up O
- O
regulated O
in O
several O
cancers O
, O
including O
HCC O
, O
GC O
and O
lung B-Disease
cancer I-Disease

In O
our O
study O
, O
we O
found O
that O
lncRNA O
Chaer B-RNA
was O
highly O
expressed O
in O
the O
serum O
of O
patients O
with O
atherosclerosis B-Disease
, O
as O
well O
as O
in O
the O
aortic O
plaques O
of O
ApoE O
- O
/ O
- O
mice O
. O

In O
our O
research O
, O
HAS2 B-RNA
- I-RNA
AS1 I-RNA
expression O
was O
elevated O
in O
glioma B-Disease
tissues O
compared O
with O
normal O
brain O
tissues O

In O
conclusions O
, O
we O
demonstrated O
that O
HNF1A B-RNA
- I-RNA
AS1 I-RNA
plays O
an O
important O
regulatory O
role O
in O
bladder B-Disease
cancer I-Disease
and O
shed O
new O
light O
on O
lncRNA O
- O
directed O
diagnostic O
and O
therapeutics O
in O
bladder B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
these O
results O
suggest O
that O
high O
expression O
of O
NEAT1 B-RNA
promoted O
the O
onset O
of O
thyroid B-Disease
carcinoma I-Disease
. O

In O
conclusion O
, O
the O
results O
of O
the O
present O
study O
indicated O
that O
lnPTENP1 B-RNA
may O
inhibit O
osteosarcoma B-Disease
cell O
growth O
via O
the O
PI3K O
/ O
AKT O
signaling O
pathway O
, O
which O
may O
be O
a O
potential O
novel O
target O
for O
human O
osteosarcoma B-Disease
therapy O
. O

In O
conclusion O
, O
the O
results O
of O
the O
present O
study O
indicated O
that O
H19 B-RNA
may O
serve O
an O
oncogenic O
function O
in O
retinoblastoma B-Disease
cells O
and O
tissues O
, O
suggesting O
that O
inhibition O
of O
H19 B-RNA
may O
be O
a O
potential O
target O
mechanism O
for O
retinoblastoma B-Disease
therapy O
. O

In O
conclusion O
, O
our O
results O
disclose O
a O
novel O
NEAT1 O
/ O
miR B-RNA
- I-RNA
122 I-RNA
/ O
KLF6 B-RNA
signaling O
cascade O
in O
liver B-Disease
fibrosis I-Disease
and O
further O
identify O
the O
importance O
of O
NEAT1 O
in O
promoting O
liver B-Disease
fibrosis I-Disease
. O

In O
a O
word O
, O
our O
research O
indicates O
that O
circ B-RNA
- I-RNA
ZNF609 I-RNA
functions O
as O
a O
ceRNA O
to O
regulate O
FOXP4 O
expression O
by O
sponging O
miR B-RNA
- I-RNA
138 I-RNA
- I-RNA
5p I-RNA
has O
great O
significance O
in O
the O
pathogenesis O
of O
renal B-Disease
carcinoma I-Disease
. O

Impact O
statement O
LncRNA O
BCAR4 B-RNA
promoted O
chondrosarcoma B-Disease
cell O
proliferation O
and O
migration O
through O
activation O
of O
mTOR O
signaling O
pathway O
, O
and O
thus O
contributed O
to O
chondrosarcoma B-Disease
progression O
. O

hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
72309 I-RNA
expression O
in O
breast B-Disease
cancer I-Disease
tissues O
was O
upregulated O
relative O
to O
that O
in O
adjacent O
normal O
tissues O
. O

Hsa O
_ O
circ O
_ O
11385 O
upregulated O
in O
thyroid B-Disease
cancer I-Disease
; O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
11385 I-RNA
knockdown O
inhibited O
thyroid B-Disease
cancer I-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
, O
and O
promoted O
cell O
cycle O
arrest O
and O
apoptosis O
. O

hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
7534 I-RNA
serves O
as O
an O
oncogene O
in O
glioma B-Disease
via O
promoting O
ZIC5 O
expression O
by O
repressing O
miR B-RNA
- I-RNA
761 I-RNA
availability O
. O

Hsa O
_ O
circ O
_ O
5075 O
was O
overexpressed O
in O
colorectal B-Disease
cancer I-Disease
tissues O
compared O
with O
paracancerous O
tissues O
and O
intestinal O
polyps O
. O

hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
4771 I-RNA
and O
Zinc O
finger O
E O
- O
box O
binding O
homeobox O
2 O
( O
ZEB2 O
) O
expression O
levels O
were O
up O
- O
regulated O
and O
positively O
correlated O
in O
breast B-Disease
cancer I-Disease
tumor O
tissues O
. O

Hsa O
_ O
circ O
_ O
885 O
expression O
was O
significantly O
increased O
in O
tissue O
and O
serum O
samples O
from O
patients O
with O
osteosarcoma B-Disease
, O

Hsa O
_ O
circ O
_ O
96 O
was O
found O
to O
be O
significantly O
downregulated O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
gastric B-Disease
cancer I-Disease
cell O
lines O
compared O
with O
paired O
adjacent O
non O
- O
tumorous O
tissues O
and O
normal O
gastric O
epithelial O
cells O

HOXD B-RNA
- I-RNA
AS2 I-RNA
was O
increased O
in O
glioma B-Disease
cells O
and O
it O
was O
associated O
with O
glioma B-Disease
grade O
and O
poor O
prognosis O
. O

HOTAIRM1 B-RNA
, O
which O
was O
downregulated O
in O
HCC O
, O
might O
inhibit O
the O
proliferative O
ability O
and O
promote O
the O
apoptosis O
of O
HCC O
cells O
by O
suppressing O
the O
Wnt O
pathway O
, O
thereby O
inhibiting O
the O
progression O
of O
hepatocellular B-Disease
carcinoma I-Disease
. O

Highly O
expressed O
lncRNA O
CCND2 B-RNA
- I-RNA
AS1 I-RNA
promotes O
glioma B-Disease
cell O
proliferation O
through O
Wnt O
/ O
β O
- O
catenin O
signaling O
. O

High O
LINC00536 B-RNA
expression O
promotes O
tumor O
progression O
and O
poor O
prognosis O
in O
bladder B-Disease
cancer I-Disease
. O

High O
levels O
ofLincIN O
expression O
are O
frequently O
observed O
in O
tumors O
compared O
to O
adjacent O
normal O
tissues O
, O
and O
are O
strongly O
associated O
with O
aggressive O
breast B-Disease
cancer I-Disease
. O

High O
expression O
of O
lncRNA O
SNHG16 B-RNA
( O
small O
nucleolar O
RNAhostgene16 O
) O
was O
discovered O
in O
gastric B-Disease
cancer I-Disease
( O
GC O
) O
and O
many O
other O
tumors O
. O

Here O
, O
we O
found O
that O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
was O
highly O
expressed O
in O
glioma B-Disease
tissues O
, O
being O
closely O
related O
to O
clinical O
stage O
of O
glioma B-Disease
. O

Here O
, O
we O
found O
that O
MT1JP B-RNA
expression O
was O
significantly O
down O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
, O
and O
that O
decreased O
MT1JP B-RNA
expression O
was O
associated O
with O
breast B-Disease
cancer I-Disease
progression O
and O
poor O
survival O
of O
breast B-Disease
cancer I-Disease
patients O
. O

Here O
, O
we O
found O
that O
lncRNA O
LINC00473 B-RNA
is O
significantly O
upregulated O
in O
breast B-Disease
cancer I-Disease
cells O
. O

Here O
, O
we O
found O
that O
circRNA O
UBAP2 O
( O
circUBAP2 B-RNA
) O
expression O
is O
significantly O
increased O
in O
human O
osteosarcoma B-Disease
tissues O
as O
compared O
to O
those O
in O
matched O
controls O
. O

Here O
we O
report O
the O
discovery O
of O
the O
noncoding O
RNA O
, O
Flicr B-RNA
, O
and O
its O
finetuning O
of O
FoxP3 O
expression O
through O
modification O
of O
chromatin O
accessibility O
, O
with O
marked O
consequences O
on O
the O
progression O
of O
autoimmune B-Disease
diabetes I-Disease

Here O
we O
demonstrate O
that O
a O
nuclear O
lncRNA O
LINC00336 B-RNA
is O
upregulated O
in O
lung B-Disease
cancer I-Disease
and O
functions O
as O
an O
oncogene O
by O
acting O
as O
a O
competing O
endogenous O
RNA O
( O
ceRNAs O
) O
. O

Further O
study O
suggested O
that O
lncRNA B-RNA
- I-RNA
PE I-RNA
downregulated O
miR B-RNA
- I-RNA
200a I-RNA
/ I-RNA
b I-RNA
by O
repressing O
the O
primary O
transcript O
expression O
, O
enhanced O
ZEB1 O
expression O
, O
and O
promoted O
epithelial O
- O
mesenchymal O
transition O
of O
hepatocellular B-Disease
carcinoma I-Disease
cells O
. O

Functional O
experiments O
showed O
that O
enhanced O
expression O
of O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
promotes O
osteosarcoma B-Disease
cells O
proliferation O
and O
migration O
. O

FAM84B B-RNA
- I-RNA
AS I-RNA
promotes O
gastric B-Disease
cancer I-Disease
proliferation O
through O
inhibition O
of O
apoptosis O
signaling O
pathways O
and O
promotes O
drug O
resistance O
of O
gastric B-Disease
cancer I-Disease
cells O
to O
platinum O
drugs O
through O
its O
apoptosis O
- O
inhibiting O
functions O
. O

Expressions O
of O
ECONEXIN B-RNA
and O
C130071C03Rik B-RNA
were O
significantly O
upregulated O
in O
both O
human O
and O
mouse O
glioma B-Disease
tissues O
. O

Expression O
of O
HOXA11 B-RNA
- I-RNA
AS I-RNA
was O
significantly O
up O
- O
regulated O
in O
glioma B-Disease
tissue O
and O
cell O
lines O
compared O
to O
the O
adjacent O
normal O
tissue O
and O
cells O
. O

Elevated O
TFAP4 B-RNA
regulates O
lncRNA O
TRERNA1 B-RNA
to O
promote O
cell O
migration O
and O
invasion O
in O
gastric B-Disease
cancer I-Disease
; O
TFAP4 B-RNA
specifically O
regulated O
the O
transcriptional O
activity O
of O
TRERNA1 B-RNA
by O
binding O
to O
the O
E O
box O
motifs O
in O
the O
TRERNA1 B-RNA
promoter O
; O
TRERNA1 B-RNA
was O
upregulation O
in O
gastric O
carcinogenesis O
and O
promoted O
cell O
migration O
and O
invasion O
in O
GC O
. O

EGR1 O
- O
induced O
upregulation O
of O
lncRNA O
FOXD2 B-RNA
- I-RNA
AS1 I-RNA
promotes O
the O
progression O
of O
hepatocellular B-Disease
carcinoma I-Disease
via O
epigenetically O
silencing O
DKK1 O
and O
activating O
Wnt O
/ O
β O
- O
catenin O
signaling O
pathway O
. O

EGOT B-RNA
may O
inhibit O
breast O
cancercell O
viability O
and O
migration O
via O
inactivation O
of O
the O
Hh O
pathway O
. O

Effect O
of O
long O
non O
- O
coding O
RNA O
PVT1 B-RNA
on O
cell O
proliferation O
and O
migration O
in O
melanoma B-Disease
. O

Ectopic O
expression O
of O
lncRNA O
HSPC324 B-RNA
significantly O
inhibited O
proliferation O
, O
cell O
cycle O
and O
migration O
; O
on O
the O
other O
hand O
, O
increased O
apoptosis O
and O
ROS O
production O
in O
lung B-Disease
adenocarcinoma I-Disease
cells O
. O

E2F1 O
- O
induced O
upregulation O
of O
long O
non O
- O
coding O
RNA O
LMCD1 B-RNA
- I-RNA
AS1 I-RNA
facilitates O
cholangiocarcinoma B-Disease
cell O
progression O
by O
regulating O
miR O
- O
345 O
- O
5p O
/ O
COL6A3 O
pathway O
. O

Down O
- O
regulation O
of O
the O
IGF B-RNA
- I-RNA
2 I-RNA
/ O
H19 B-RNA
locus O
during O
normal O
and O
malignant O
hematopoiesis B-Disease
is O
independent O
of O
the O
imprinting O
pattern O
. O

Down O
- O
regulation O
of O
snaR B-RNA
inhibited O
the O
proliferation O
, O
migration O
, O
and O
invasion O
of O
MDA O
- O
MD O
- O
231 O
breast B-Disease
cancer I-Disease
cells O
. O

Downregulation O
of O
lncRNA B-RNA
- I-RNA
ATB I-RNA
significantly O
inhibited O
the O
tumorigenesis O
of O
ovarian B-Disease
cancer I-Disease
in O
vitro O
and O
in O
vivo O

Down O
- O
regulation O
of O
DANCR B-RNA
acts O
as O
a O
potential O
biomarker O
for O
papillary B-Disease
thyroid I-Disease
cancer I-Disease
diagnosis O
. O

Downregulated O
lncRNA O
ADAMTS9 B-RNA
- I-RNA
AS2 I-RNA
in O
breast B-Disease
cancer I-Disease
enhances O
tamoxifen O
resistance O
by O
activating O
microRNA B-RNA
- I-RNA
130a I-RNA
- I-RNA
5p I-RNA
. O

Downregulated O
CAIF B-RNA
was O
observed O
in O
end B-Disease
- I-Disease
stage I-Disease
cardiomyopathy I-Disease
patients O
than O
in O
healthy O
controls O
. O

DNA O
demethylating O
drugs O
reduce O
mouse O
insulinoma B-Disease
cell O
proliferation O
and O
restore O
MEG3 O
expression O
. O

DGCR9 B-RNA
was O
upregulated O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
was O
shown O
to O
accelerate O
cellular O
proliferation O
, O
migration O
, O
and O
glucose O
metabolism O
, O
all O
of O
which O
would O
promote O
the O
formation O
and O
development O
of O
gastric B-Disease
cancer I-Disease
. O

Decreased O
expression O
of O
long O
noncoding O
RNA O
XLOC B-RNA
_ I-RNA
13703 I-RNA
promotes O
cell O
growth O
via O
NF O
- O
κ O
B O
pathway O
in O
multiple B-Disease
myeloma I-Disease
. O

Decreased O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
1895 I-RNA
in O
human O
gastric B-Disease
cancer I-Disease
and O
its O
clinical O
significances O
. O

Compared O
with O
the O
adjacent O
tissues O
, O
we O
found O
that O
BCAR4 B-RNA
was O
highly O
expressed O
in O
gastric B-Disease
cancer I-Disease
tissues O
. O

Compared O
with O
normal O
counterparts O
, O
PVT1 B-RNA
is O
upregulated O
in O
human O
hepatoblastoma B-Disease
tissues O
as O
well O
as O
in O
hepatoblastoma B-Disease
cell O
lines O
. O

Compared O
with O
adjacent O
tissues O
, O
PVT1 B-RNA
, O
HCG18 B-RNA
, O
EXOC3 B-RNA
- I-RNA
AS1 I-RNA
were O
upregulated O
in O
most O
lung B-Disease
cancer I-Disease
tissues O
. O

Collectively O
, O
these O
results O
indicate O
that O
overexpression O
of O
SNHG5 B-RNA
promotes O
tumor O
growth O
in O
breast B-Disease
cancer I-Disease
cells O
both O
in O
vitro O
and O
in O
vivo O
. O

Collectively O
, O
our O
study O
demonstrated O
that O
lncRNA O
- O
ATB O
is O
upregulated O
in O
osteosarcoma B-Disease
patient O
' O
s O
serum O
and O
tissues O
, O
promotes O
osteosarcoma B-Disease
cell O
proliferation O
, O
migration O
, O
and O
invasion O
in O
vitro O
, O
and O
osteosarcoma B-Disease
tumor O
growth O
in O
vivo O
through O
inhibiting O
miR B-RNA
- I-RNA
200s I-RNA
pathway O
. O

CircZNF609 O
was O
significantly O
upregulated O
in O
U251 O
and O
U87 O
cells O
and O
acted O
as O
an O
oncogene O
to O
promote O
cell O
proliferation O
and O
cell O
migration O
of O
glioma B-Disease
cell O
U251 O
and O
U87 O
. O

circulating O
levels O
of O
cZNF609 B-RNA
were O
down O
- O
regulated O
in O
the O
patients O
with O
coronary B-Disease
artery I-Disease
disease I-Disease
( O
CAD O
) O
or O
hypertension O
compared O
with O
healthy O
volunteers O

Functional O
experiments O
validated O
that O
cir B-RNA
- I-RNA
GLI2 I-RNA
exerted O
the O
tumor O
- O
promoting O
effects O
on O
osteosarcoma B-Disease
cells O
via O
negatively O
targeting O
miR B-RNA
- I-RNA
125b I-RNA
- I-RNA
5p I-RNA
. O

Circular O
RNA O
circVAPA B-RNA
is O
up O
- O
regulated O
and O
exerts O
oncogenic O
properties O
by O
sponging O
miR B-RNA
- I-RNA
101 I-RNA
in O
colorectal B-Disease
cancer I-Disease
. O

CircDENND4C O
is O
a O
HIF1 O
α O
- O
associated O
circRNA O
promoting O
the O
proliferation O
of O
breast B-Disease
cancer I-Disease
cells O
under O
hypoxia O
. O

CircCCDC66 O
expression O
was O
elevated O
in O
polyps O
and O
colon B-Disease
cancer I-Disease
and O
was O
associated O
with O
poor O
prognosis O
. O

CDKN2B B-RNA
- I-RNA
AS1 I-RNA
is O
significantly O
upregulated O
in O
most O
of O
the O
tumor O
cancer O
cells O
, O
including O
cervical B-Disease
cancer I-Disease

Carboplatin O
- O
docetaxel O
- O
induced O
activity O
against O
ovarian B-Disease
cancer I-Disease
is O
dependent O
on O
up O
- O
regulated O
lncRNA O
PVT1 B-RNA
. O

BLACAT1 B-RNA
knockdown O
inhibited O
the O
progression O
of O
ovarian B-Disease
cancer I-Disease
by O
suppressing O
the O
Wnt O
/ O
β O
- O
catenin O
signaling O
pathway O
via O
regulating O
miR B-RNA
- I-RNA
519d I-RNA
- I-RNA
3p I-RNA
. O

ASB16 B-RNA
- I-RNA
AS1 I-RNA
Expression O
Levels O
Are O
Significantly O
Upregulated O
in O
Human O
Glioma O
Tissues O
and O
Correlate O
with O
WHO O
Grade O
. O

Among O
the O
various O
tested O
cancerous O
tissue O
samples O
, O
three O
demonstrated O
overexpression O
of O
LINC B-RNA
- I-RNA
ROR I-RNA
including O
cervical O
, O
ovarian O
, O
and O
esophageal O
cancers O
. O

In O
contrast O
, O
the O
expression O
in O
breast O
, O
melanoma O
, O
colon O
, O
and O
sarcoma B-Disease
tumors O
was O
mainly O
reduced O
compared O
to O
normal O
controls O

Allelic O
methylation O
of O
H19 B-RNA
and O
IGF2 B-RNA
in O
the O
Beckwith O
- O
Wiedemann O
syndrome O
. O

All O
the O
results O
above O
explained O
that O
SNHG3 B-RNA
accelerated O
prostate B-Disease
cancer I-Disease
progression O
by O
sponging O
miR O
- O
577 O
to O
up O
- O
regulate O
SMURF1 O
expression O
, O
suggesting O
that O
SNHG3 B-RNA
may O
act O
as O
a O
biomarker O
for O
prostate B-Disease
cancer I-Disease
patients O
. O

Afterward O
, O
overexpression O
of O
circLMTK2 B-RNA
was O
performed O
in O
gastric B-Disease
cancer I-Disease
cell O
line O
MGC O
- O
803 O
, O
and O
results O
indicated O
that O
malignant O
biological O
properties O
were O
inhibited O
by O
circLTMK2 O
overexpression O
. O

After O
transfected O
with O
the O
long O
non O
- O
coding O
PCAT B-RNA
- I-RNA
1 I-RNA
siRNA O
into O
cervical B-Disease
cancer I-Disease
cell O
lines O
for O
48 O
h O
, O
the O
lncRNA O
PCAT B-RNA
- I-RNA
1 I-RNA
cells O
were O
significantly O
down O
- O
regulated O
. O

AFAP1 B-RNA
- I-RNA
AS1 I-RNA
was O
highly O
expressed O
both O
in O
ovarian B-Disease
cancer I-Disease
samples O
and O
cell O
lines O
compared O
with O
their O
corresponding O
normal O
counterparts O
. O

According O
to O
the O
results O
, O
TUBA4B B-RNA
was O
largely O
downregulated O
in O
breast B-Disease
cancer I-Disease
samples O
and O
cell O
lines O
. O

According O
to O
all O
findings O
, O
we O
concluded O
that O
HOXD O
- O
AS1 O
acted O
as O
a O
ceRNA O
to O
enhance O
the O
cisplatin O
- O
resistance O
of O
cervical B-Disease
cancer I-Disease
cells O
through O
targeting O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
130a I-RNA
- I-RNA
3p I-RNA
/ O
ZEB1 B-RNA
. O

A O
' O
slipped O
mispairing O
' O
mechanism O
occurring O
during O
dna O
replication O
may O
generate O
p53 B-RNA
intragenic O
deletion O
in O
human O
esophageal B-Disease
cancer I-Disease
, O
leading O
to O
abolished O
p53 B-RNA
mrna O
expression O
. O

A O
novel O
long O
non O
- O
coding O
RNA O
- O
KAT7 B-RNA
is O
low O
expressed O
in O
colorectal B-Disease
cancer I-Disease
and O
acts O
as O
a O
tumor O
suppressor O
. O

A O
novel O
long O
non O
- O
coding O
RNA O
lnc O
- O
GNAT1 B-RNA
- I-RNA
1 I-RNA
is O
low O
expressed O
in O
colorectal B-Disease
cancer I-Disease
and O
acts O
as O
a O
tumor O
suppressor O
through O
regulating O
RKIP O
- O
NF O
- O
κ O
B O
- O
Snail O
circuit O
. O

A O
higher O
level O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
1783 I-RNA
was O
significantly O
correlated O
with O
heavier O
tumor O
burden O
and O
poorer O
prognosis O
of O
patients O
with O
breast B-Disease
cancer I-Disease
. O

Functional O
assays O
proved O
that O
up O
- O
regulation O
of O
WT1 B-RNA
- I-RNA
AS I-RNA
significantly O
suppressed O
cervical B-Disease
cancer I-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
. O

When O
comparing O
lung B-Disease
cancer I-Disease
tissues O
with O
their O
adjacent O
normal O
tissues O
, O
the O
expression O
of O
lnc B-RNA
- I-RNA
BMP1 I-RNA
- I-RNA
1 I-RNA
were O
decreased O
, O
especially O
in O
patients O
with O
cigarette O
smoking O
history O
( O
P O
= O
0 O
. O
27 O
) O
, O
and O
positively O
associated O
with O
the O
expression O
of O
Cav O
- O
1 O
( O
P O
< O
0 O
. O
1 O
) O
. O

We O
then O
found O
that O
the O
expression O
of O
FTX B-RNA
and O
miR B-RNA
- I-RNA
342 I-RNA
- I-RNA
3p I-RNA
was O
associated O
with O
progression O
of O
gliomas O
. O

FTX B-RNA
directly O
inhibited O
the O
expression O
of O
miR B-RNA
- I-RNA
342 I-RNA
- I-RNA
3p I-RNA
, O
which O
subsequently O
regulates O
the O
expression O
of O
AEG O
- O
1 O
. O

we O
recognized O
a O
lncRNA O
, O
LNC B-RNA
CRYBG3 I-RNA
, O
which O
can O
interact O
with O
lactate O
dehydrogenase O
A O
( O
LDHA O
) O
, O
a O
vital O
enzyme O
of O
glycolysis O
, O
is O
highly O
upregulated O
in O
both O
clinical O
lung B-Disease
cancer I-Disease
tissues O
and O
in O
vitro O
cultured O
lung B-Disease
cancer I-Disease
cell O
lines O
. O
the O
knockdown O
of O
LNC B-RNA
CRYBG3 I-RNA
led O
to O
opposite O
results O
and O
suppressed O
cell O
proliferation O
. O

We O
observed O
that O
increased O
expression O
of O
LINC00319 B-RNA
in O
lung B-Disease
adenocarcinoma I-Disease
tissues O
and O
cells O
in O
comparison O
to O
their O
corresponding O
controls O
. O

Moreover O
, O
the O
aberrant O
overexpression O
of O
LINC00319 B-RNA
indicated O
the O
poor O
prognosis O
of O
lung B-Disease
adenocarcinoma I-Disease
patients O
. O

We O
identified O
that O
the O
expression O
level O
of O
TP73 B-RNA
- I-RNA
AS1 I-RNA
was O
significantly O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
compared O
to O
adjacent O
non O
- O
tumor O
tissues O
. O

We O
found O
that O
the O
UCA1 B-RNA
was O
highly O
expressed O
in O
the O
normal O
fibroblast O
- O
like O
synoviocyte O
( O
NFLS O
) O
, O
compared O
with O
the O
fibroblast O
- O
like O
synoviocyte O
of O
rheumatoid B-Disease
arthritis I-Disease
( O
RAFLS O
) O
. O

Overexpression O
of O
NEAT1 B-RNA
promoted O
the O
proliferation O
and O
migration O
of O
cervical B-Disease
cancer I-Disease
cells O
. O

Molecular O
studies O
uncovered O
that O
NEAT1 B-RNA
functions O
as O
competitive O
endogenous O
RNA O
( O
ceRNA O
) O
, O
binding O
the O
micro O
- O
RNA O
miR B-RNA
- I-RNA
9 I-RNA
- I-RNA
5p I-RNA
and O
suppressing O
its O
expression O
. O

We O
found O
that O
the O
level O
of O
circNHSL1 B-RNA
was O
significantly O
up O
- O
regulated O
in O
gastric B-Disease
cancer I-Disease
, O
and O
positively O
correlated O
with O
clinicopathological O
features O
and O
poor O
prognosis O
of O
patients O
with O
gastric B-Disease
cancer I-Disease
. O

We O
found O
that O
the O
level O
of O
circCLK3 O
was O
remarkably O
higher O
in O
cervical B-Disease
cancer I-Disease
tissues O
than O
in O
adjacent O
normal O
tissues O
, O
and O
closely O
associated O
with O
tumor O
differentiation O
, O
FIGO O
stage O
and O
depth O
of O
stromal O
invasion O
. O

We O
found O
that O
the O
Chaer B-RNA
was O
highly O
expressed O
in O
serum O
samples O
from O
28 O
patients O
with O
atherosclerosis B-Disease
, O
compared O
with O
28 O
healthy O
volunteers O
. O

We O
found O
that O
lncAKHE B-RNA
was O
highly O
expressed O
in O
hepatocellular B-Disease
carcinoma I-Disease
tissues O
. O
lncAKHE B-RNA
depletion O
remarkably O
impaired O
the O
abilities O
of O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
in O
hepatocellular B-Disease
carcinoma I-Disease
while O
promgoogoting O
cell O
apoptosis O
. O

We O
found O
that O
LINC01617 B-RNA
was O
overexpressed O
in O
esophageal B-Disease
cancer I-Disease
, O
and O
its O
expression O
was O
associated O
with O
poor O
prognosis O
of O
esophageal B-Disease
cancer I-Disease
. O
knockout O
of O
LINC01617 B-RNA
significantly O
inhibited O
the O
proliferation O
, O
migration O
and O
invasion O
of O
esophageal B-Disease
cancer I-Disease
cells O
. O

overexpression O
of O
LINC00961 B-RNA
significantly O
suppressed O
glioma B-Disease
cells O
proliferation O
, O
migration O
, O
and O
invasion O
. O

Mechanistically O
, O
we O
found O
that O
overexpression O
of O
LINC00961 B-RNA
inhibited O
glioma B-Disease
cell O
EMT O
. O

We O
found O
that O
LINC00641 B-RNA
expression O
was O
significantly O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
. O

Down O
- O
regulation O
of O
LINC00641 B-RNA
in O
patients O
with O
bladder B-Disease
cancer I-Disease
predicts O
poor O
prognosis O
. O

Gain O
- O
of O
- O
function O
assays O
indicated O
that O
LINC00641 B-RNA
up O
- O
regulation O
markedly O
inhibited O
the O
proliferation O
, O
migration O
and O
invasion O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

LINC00641 B-RNA
was O
demonstrated O
to O
interact O
with O
miR B-RNA
- I-RNA
197 I-RNA
- I-RNA
3p I-RNA
. O

Moreover O
, O
increased O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
137439 I-RNA
was O
correlated O
with O
higher O
tumor O
stage O
, O
higher O
tumor O
grade O
, O
higher O
lymph O
node O
status O
, O
and O
history O
of O
muscle O
- O
invasive O
bladder B-Disease
cancer I-Disease
( O
MIBC O
) O
. O

We O
found O
that O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
57481 I-RNA
was O
significantly O
upregulated O
in O
laryngeal B-Disease
cancer I-Disease
tissues O
compared O
with O
healthy O
normal O
specimens O
. O

We O
found O
that O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
993 I-RNA
inhibited O
migration O
, O
invasion O
and O
proliferation O
of O
gastric B-Disease
cancer I-Disease
cells O
and O
could O
act O
as O
a O
miRNA O
sponge O
for O
miR B-RNA
- I-RNA
214 I-RNA
- I-RNA
5p I-RNA
but O
did O
not O
modulate O
expression O
of O
its O
parental O
gene O
, O
ATL2 O
. O

We O
found O
that O
high O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
326 I-RNA
was O
correlated O
with O
tumor O
size O
, O
regional O
lymph O
node O
status O
and O
differentiation O
in O
human O
lung B-Disease
adenocarcinoma I-Disease
. O

We O
found O
that O
circWHSC1 O
was O
up O
- O
regulated O
in O
ovarian B-Disease
cancer I-Disease
tissues O
, O
and O
circWHSC1 O
expression O
was O
higher O
in O
moderate O
& O
poor O
differentiation O
ovarian B-Disease
cancer I-Disease
tissues O
than O
in O
well O
differentiation O
ovarian B-Disease
cancer I-Disease
tissues O
. O

We O
found O
that O
circEPSTI1 B-RNA
was O
significantly O
upregulated O
in O
osteosarcoma B-Disease
. O

Inhibition O
of O
circEPSTI1 B-RNA
suppressed O
the O
osteosarcoma B-Disease
cancer O
cell O
proliferation O
and O
migration O
in O
vitro O
. O

we O
found O
that O
circEHMT1 B-RNA
inhibited O
migration O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O
. O

We O
found O
that O
circCPA4 O
( O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
82374 I-RNA
) O
up O
- O
regulated O
the O
most O
in O
glioma B-Disease
tissues O
and O
high O
levels O
of O
circCPA4 O
were O
positively O
related O
to O
poor O
outcome O
of O
glioma B-Disease
. O

CircABCC4 B-RNA
knockdown O
markedly O
suppressed O
prostate B-Disease
cancer I-Disease
cell O
proliferation O
, O
cell O
- O
cycle O
progression O
, O
migration O
and O
invasion O
in O
vitro O
. O

LncRNA O
HULC B-RNA
can O
promote O
the O
tumorigenesis O
of O
bone B-Disease
neoplasms I-Disease
through O
increasing O
the O
proliferation O
, O
invasion O
, O
and O
migration O
abilities O
and O
the O
expression O
level O
of O
EMT O
- O
related O
factors O
. O

We O
discovered O
that O
circVAPA B-RNA
was O
dysregulated O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cells O
. O

Ectopic O
circVAPA B-RNA
regulated O
breast B-Disease
cancer I-Disease
migration O
, O
invasion O
and O
proliferation O
. O

We O
determined O
that O
attenuation O
of O
FENDRR B-RNA
was O
a O
frequent O
event O
in O
colon B-Disease
cancer I-Disease
tissues O
and O
colon B-Disease
cancer I-Disease
cell O
lines O
, O
in O
contrast O
to O
their O
normal O
counterparts O
. O

we O
demonstrated O
that O
the O
expression O
of O
circZMIZ1 B-RNA
was O
higher O
in O
plasma O
of O
human O
prostate B-Disease
cancer I-Disease
than O
the O
paired O
benign O
prostatic O
hyperplasia O
( O
BPH O
) O
patients O
' O
plasma O
. O

Moreover O
, O
in O
cultured O
prostate B-Disease
cancer I-Disease
cells O
, O
knockdown O
of O
circZMIZ1 B-RNA
inhibited O
cell O
proliferation O
and O
caused O
cell O
cycle O
arrest O
at O
G1 O
. O

We O
demonstrated O
that O
increased O
LINC01296 B-RNA
expression O
is O
a O
common O
event O
underlying O
prostate B-Disease
cancer I-Disease
, O
suggesting O
that O
LINC01296 B-RNA
acts O
as O
an O
independent O
negative O
prognosis O
factor O
for O
prostate B-Disease
cancer I-Disease
patients O
. O

We O
demonstrated O
a O
low O
NKILA B-RNA
expression O
in O
laryngeal B-Disease
cancer I-Disease
and O
its O
correlation O
with O
shorter O
overall O
survival O
in O
patients O
with O
laryngeal B-Disease
cancer I-Disease
. O

We O
confirm O
that O
CRNDE B-RNA
acts O
as O
an O
oncogene O
that O
is O
highly O
up O
- O
regulated O
in O
glioma B-Disease
, O
and O
high O
CRNDE B-RNA
expression O
correlates O
with O
poor O
prognosis O
in O
glioma B-Disease
patients O
. O

VPS9D1 B-RNA
- I-RNA
AS1 I-RNA
expression O
level O
was O
markedly O
correlated O
with O
tumor O
size O
and O
TNM O
stage O
in O
gastric B-Disease
cancer I-Disease
. O
low O
expression O
of O
VPS9D1 B-RNA
- I-RNA
AS1 I-RNA
were O
correlated O
with O
poor O
overall O
and O
disease O
free O
survival O
. O

Up O
- O
regulation O
of O
three O
lncRNAs O
CAT266 B-RNA
, O
CAT1297 B-RNA
, O
and O
CAT1647 B-RNA
in O
bladder B-Disease
cancer I-Disease
, O
in O
comparison O
to O
normal O
urothelium O
, O
was O
confirmed O
in O
an O
independent O
series O
of O
normal O
, O
non O
- O
muscle O
invasive O
( O
NMIBC O
) O
and O
MIBC O
tissue O
samples O
. O

Upregulation O
of O
PRKCQ B-RNA
- I-RNA
AS1 I-RNA
was O
related O
to O
a O
significant O
decrease O
in O
survival O
of O
colorectal B-Disease
cancer I-Disease
( O
CRC O
) O
patients O
. O

High O
lncRNA B-RNA
- I-RNA
CIR I-RNA
levels O
also O
dictated O
poor O
overall O
survival O
among O
patients O
with O
bladder B-Disease
cancer I-Disease
. O

Up O
- O
regulated O
POU6F2 B-RNA
- I-RNA
AS2 I-RNA
promoted O
cell O
proliferation O
and O
cell O
cycle O
of O
colon B-Disease
cancer I-Disease
cells O
. O

Up O
- O
regulated O
lncRNA O
AFAP1 B-RNA
- I-RNA
AS1 I-RNA
indicates O
a O
poor O
prognosis O
in O
breast B-Disease
cancer I-Disease
patients O
and O
regulated O
the O
breast B-Disease
cancer I-Disease
cells O
proliferation O
, O
apoptosis O
and O
metastasis O
. O

Functionalinvestigatio O
indicated O
that O
LINC00963 B-RNA
knockdown O
dramatically O
suppressed O
melanoma B-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
. O

In O
addition O
, O
knockdown O
of O
UCA1 B-RNA
significantly O
inhibited O
the O
proliferation O
and O
migration O
of O
medulloblastoma B-Disease
cells O
in O
vitro O
. O

TUSC7 B-RNA
was O
poorly O
expressed O
in O
tissues O
and O
cell O
lines O
of O
glioma B-Disease
, O
and O
the O
lower O
expression O
was O
correlated O
with O
glioma B-Disease
of O
the O
worse O
histological O
grade O
. O

Moreover O
, O
TUSC7 B-RNA
is O
a O
prognostic O
biomarker O
of O
glioma B-Disease
patients O
. O

TUG1 B-RNA
contributes O
to O
the O
progression O
of O
thyroid B-Disease
cancer I-Disease
cells O
through O
regulating O
miR O
- O
145 O
/ O
ZEB1 O
signal O
pathway O
. O

TTN B-RNA
- I-RNA
AS1 I-RNA
enhanced O
the O
proliferation O
, O
migration O
, O
invasion O
, O
and O
epithelial O
- O
mesenchymal O
transformation O
of O
breast B-Disease
cancer I-Disease
cells O
. O

In O
conclusion O
, O
our O
findings O
demonstrated O
that O
lncRNA O
SRA B-RNA
is O
highly O
correlated O
with O
cancer O
progression O
and O
cervical B-Disease
cancer I-Disease
cell O
proliferation O
and O
migration O
. O

In O
summary O
, O
our O
results O
reveal O
that O
autophagy O
may O
be O
tractable O
as O
a O
therapeutic O
target O
and O
DYNLRB2 B-RNA
- I-RNA
2 I-RNA
may O
be O
a O
promising O
drug O
to O
treat O
atherosclerosis B-Disease
. O

Our O
findings O
implied O
that O
LINC00657 B-RNA
can O
regulate O
ZEB1 O
expression O
by O
acting O
as O
a O
sponge O
of O
miR B-RNA
- I-RNA
136 I-RNA
in O
neuropathic B-Disease
pain I-Disease
development O
. O

The O
findings O
of O
the O
present O
study O
indicate O
that O
GAPLINC B-RNA
serves O
an O
important O
fucntion O
in O
bladder B-Disease
cancer I-Disease
and O
may O
serve O
a O
novel O
therapeutic O
target O
. O

Moreover O
, O
inhibiting O
BORG B-RNA
expression O
in O
metastatic O
breast B-Disease
cancer I-Disease
cells O
impedes O
their O
metastatic O
colonization O
of O
the O
lungs O
of O
mice O
, O
implying O
that O
BORG B-RNA
acts O
as O
a O
novel O
driver O
of O
the O
genetic O
and O
epigenetic O
alterations O
that O
underlie O
the O
acquisition O
of O
metastatic O
and O
recurrent O
phenotypes O
by O
breast B-Disease
cancer I-Disease
cells O
. O

Together O
, O
our O
study O
reveals O
that O
miR B-RNA
- I-RNA
485 I-RNA
- I-RNA
5p I-RNA
could O
be O
a O
potential O
marker O
in O
cardiac B-Disease
hypertrophy I-Disease
and O
it O
is O
a O
positive O
regulator O
in O
cardiomyocytes O
protection O
against O
mitochondrial O
fission O
induced O
pathological O
hypertrophy O
. O

The O
siRNA O
- O
mediated O
knockdown O
of O
GACAT3 B-RNA
significantly O
decreased O
cell O
proliferation O
of O
the O
gastric B-Disease
cancer I-Disease
HGC O
- O
27 O
cells O
, O
in O
which O
GACAT3 B-RNA
is O
overexpressed O
. O

NKILA B-RNA
- O
inhibited O
rectal B-Disease
cancer I-Disease
cell O
proliferation O
, O
migration O
, O
and O
invasion O
via O
suppressing O
NF O
- O
κ O
B O
signaling O
. O

The O
in O
vitro O
experiments O
showed O
that O
down O
- O
regulation O
of O
PlncRNA B-RNA
- I-RNA
1 I-RNA
expression O
suppressed O
retinoblastoma B-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
through O
up O
- O
regulating O
CBR3 O
. O

The O
results O
showed O
that O
XIST B-RNA
was O
significantly O
up O
- O
regulated O
in O
osteosarcoma B-Disease
tissues O
and O
cell O
lines O
, O
and O
high O
XIST B-RNA
expression O
was O
significantly O
associated O
with O
advanced O
tumor O
size O
( O
p O
= O
0 O
. O
9 O
) O
, O
advanced O
clinical O
stage O
( O
p O
= O
0 O
. O
1 O
) O
and O
present O
distant O
metastasis O
( O
p O
= O
0 O
. O
9 O
) O
. O

The O
results O
showed O
that O
LINC00308 B-RNA
, O
LINC00355 B-RNA
, O
and O
OSTN B-RNA
- I-RNA
AS1 I-RNA
are O
overexpressed O
in O
the O
prostate B-Disease
cancer I-Disease
cell O
line O
compared O
to O
the O
normal O
myofibroblast O
stromal O
cell O
line O
. O

LINC00308 B-RNA
, O
LINC00355 B-RNA
, O
and O
OSTN B-RNA
- I-RNA
AS1 I-RNA
) O
were O
significantly O
associated O
with O
overall O
survival O
( O
log O
- O
rank O
P O
< O
0 O
. O
5 O
) O
. O

These O
findings O
demonstrated O
that O
LINC01082 B-RNA
may O
act O
in O
suppressing O
the O
incidence O
and O
development O
of O
colon B-Disease
cancer I-Disease
via O
suppressing O
cell O
proliferation O
, O
migration O
and O
invasion O
, O
indicating O
that O
LINC01082 B-RNA
may O
act O
as O
a O
new O
tumor O
suppressor O
and O
may O
be O
a O
promising O
therapy O
target O
for O
colon B-Disease
cancer I-Disease
. O

High O
expression O
of O
lncRNA O
CCAT1 B-RNA
was O
positively O
associated O
with O
tumor O
size O
, O
and O
there O
was O
correlation O
between O
high O
lncRNA O
CCAT1 B-RNA
expression O
and O
a O
poor O
survival O
rate O
of O
cervical B-Disease
cancer I-Disease
. O

MAGI2 B-RNA
- I-RNA
AS3 I-RNA
expression O
in O
glioma B-Disease
tissues O
was O
an O
independent O
prognostic O
factor O
for O
overall O
survival O
. O

Increased O
lncRNA O
KCNQ1OT1 B-RNA
in O
ovarian B-Disease
cancer I-Disease
cells O
promotes O
the O
expression O
of O
β O
- O
catenin O
, O
thereby O
facilitating O
the O
proliferation O
and O
migration O
of O
ovarian B-Disease
cancer I-Disease
cells O
. O

These O
new O
findings O
all O
illustrate O
that O
PANDAR B-RNA
might O
play O
a O
pivotal O
oncogenic O
role O
in O
the O
occurrence O
and O
development O
of O
melanoma B-Disease
, O
and O
PANDAR B-RNA
might O
promote O
melanoma B-Disease
cell O
invasion O
through O
regulating O
EMT O
, O
providing O
a O
potential O
diagnostic O
and O
therapeutic O
target O
for O
melanoma B-Disease
. O

The O
overall O
expression O
of O
LINC00477 B-RNA
was O
reduced O
in O
gastric O
cancers O
compared O
to O
normal O
gastric O
tissues O
. O

The O
long O
noncoding O
RNA O
NORAD B-RNA
enhances O
the O
TGF O
- O
beta O
pathway O
to O
promote O
hepatocellular B-Disease
carcinoma I-Disease
progression O
by O
targeting O
miR B-RNA
- I-RNA
202 I-RNA
- I-RNA
5p I-RNA
. O
NORAD B-RNA
overexpression O
was O
demonstrated O
to O
promote O
HCC O
cell O
migration O
and O
invasion O
. O

The O
long O
non O
- O
coding O
RNA O
LINC01606 B-RNA
contributes O
to O
the O
metastasis O
and O
invasion O
of O
human O
gastric B-Disease
cancer I-Disease
and O
is O
associated O
with O
Wnt O
/ O
beta O
- O
catenin O
signaling O
. O

The O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
affects O
the O
radiosensitivity O
of O
pancreatic B-Disease
ductal I-Disease
adenocarcinoma I-Disease
by O
regulating O
the O
expression O
of O
Wnt O
inhibitory O
factor O
1 O
. O

The O
long O
noncoding O
RNA O
H19 B-RNA
promotes O
cell O
proliferation O
via O
E2F O
- O
1 O
in O
pancreatic B-Disease
ductal I-Disease
adenocarcinoma I-Disease
. O

The O
Long O
Noncoding O
RNA O
D63785 B-RNA
Regulates O
Chemotherapy O
Sensitivity O
in O
Human O
Gastric O
Cancer O
by O
Targeting O
miR B-RNA
- I-RNA
422a I-RNA
. O

The O
lncRNA O
MIAT B-RNA
was O
overexpressed O
in O
melanoma B-Disease
. O

The O
overexpression O
of O
MIAT B-RNA
promoted O
cell O
proliferation O
, O
cell O
invasion O
and O
migration O
, O
while O
the O
knockdown O
of O
MIAT B-RNA
expression O
got O
the O
opposite O
results O
. O

the O
levels O
of O
SNHG7 B-RNA
expression O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
were O
severally O
higher O
than O
in O
normal O
adjacent O
tissues O
and O
gastric O
mucosal O
epithelial O
cells O
. O

the O
level O
of O
DARS B-RNA
- I-RNA
AS1 I-RNA
in O
tumor O
tissues O
of O
thyroid B-Disease
cancer I-Disease
patients O
was O
remarkably O
higher O
than O
that O
in O
adjacent O
tissues O
, O
and O
the O
difference O
was O
statistically O
significant O
. O

Loss O
- O
of O
- O
function O
assays O
revealed O
that O
CRNDE B-RNA
influences O
proliferation O
and O
apoptosis O
in O
cervical B-Disease
cancer I-Disease
cells O

The O
focally O
amplified O
long O
non O
- O
coding O
RNA O
in O
epithelial B-Disease
cancer I-Disease
( O
FALEC B-RNA
) O
was O
found O
downregulated O
in O
the O
tissues O
of O
tongue B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
( O
TSCC O
) O
and O
was O
predicted O
to O
present O
a O
good O
prognosis O
by O
bioinformatics O
analysis O
. O

The O
increased O
level O
of O
FER1L4 B-RNA
could O
suppress O
the O
PTX O
resistance O
of O
ovarian B-Disease
cancer I-Disease
cells O
through O
the O
inhibition O
of O
the O
MAPK O
signaling O
pathway O
. O

The O
expression O
of O
Sox2ot B-RNA
was O
overexpressed O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
. O

High O
levels O
of O
Sox2ot B-RNA
were O
correlated O
with O
malignant O
status O
and O
poor O
prognosis O
. O

The O
expression O
of O
SNHG7 B-RNA
in O
esophageal B-Disease
cancer I-Disease
tissues O
and O
cells O
was O
significantly O
up O
- O
regulated O
. O

PCA3 B-RNA
could O
promote O
cell O
proliferation O
, O
migration O
and O
invasion O
in O
gestational O
choriocarcinoma B-Disease
cells O
and O
facilitated O
epithelial O
to O
mesenchymal O
transition O
( O
EMT O
) O
in O
vitro O
. O

The O
expression O
of O
lncRNA B-RNA
- I-RNA
ZNF281 I-RNA
was O
lower O
in O
glioma B-Disease
stem O
- O
like O
cells O
( O
U251s O
) O
and O
this O
indicates O
that O
lncRNA B-RNA
- I-RNA
ZNF281 I-RNA
can O
regulate O
the O
self O
- O
renewal O
capacity O
of O
glioma B-Disease
stem O
- O
like O
cells O
and O
stem O
cell O
marker O
expression O
. O

The O
expression O
of O
lncRNA O
SNHG6 B-RNA
was O
positively O
correlated O
with O
the O
malignancy O
and O
poor O
prognosis O
of O
glioma B-Disease
patients O
. O

The O
expression O
of O
LncRNA O
GACAT3 B-RNA
was O
increased O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
compared O
to O
paracancer O
tissues O
and O
normal O
cells O
. O

Moreover O
, O
the O
gastric B-Disease
cancer I-Disease
patients O
with O
higher O
expression O
of O
lncRNA O
CADM1 B-RNA
- I-RNA
AS1 I-RNA
had O
a O
statistically O
better O
overall O
survival O
( O
OS O
) O
time O
and O
progression O
- O
free O
survival O
( O
PFS O
) O
time O
. O

EZR B-RNA
- I-RNA
AS1 I-RNA
knockdown O
significantly O
suppressed O
the O
proliferation O
and O
cell O
cycle O
progression O
of O
breast B-Disease
cancer I-Disease
cells O
while O
reducing O
cellular O
apoptosis O
. O

Functionally O
, O
knockdown O
of O
circZFR B-RNA
could O
significantly O
prohibit O
cell O
growth O
, O
migration O
and O
invasion O
, O
arrest O
cell O
cycle O
as O
well O
as O
promote O
apoptosis O
of O
bladder B-Disease
cancer I-Disease
cells O
in O
vitro O
study O
. O

the O
knockdown O
of O
circDENND4C O
suppressed O
proliferation O
, O
migration O
, O
and O
glycolysis O
of O
colorectal B-Disease
cancer I-Disease
cells O
. O

Our O
in O
vivo O
and O
in O
vitro O
data O
indicated O
that O
circACVR2A O
suppressed O
the O
proliferation O
, O
migration O
and O
invasion O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

Overexpression O
of O
CASC15 B-RNA
prohibited O
the O
malignancy O
of O
ovarian B-Disease
cancer I-Disease
cells O
, O
including O
proliferation O
, O
colony O
formation O
, O
cell O
cycle O
, O
migration O
, O
and O
invasion O
, O
and O
promoted O
cell O
apoptosis O
. O

Through O
knockdown O
of O
BCAR4 B-RNA
, O
we O
discovered O
that O
knockdown O
of O
BCAR4 B-RNA
significantly O
decreased O
the O
proliferation O
, O
migration O
and O
invasive O
abilities O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

multivariate O
analysis O
showed O
that O
relative O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
expression O
was O
an O
independent O
predictor O
of O
overall O
survival O
in O
patients O
with O
cervical B-Disease
cancer I-Disease
. O

the O
expression O
level O
of O
ZEB2 B-RNA
- I-RNA
AS1 I-RNA
in O
colon B-Disease
cancer I-Disease
tissues O
was O
significantly O
up O
- O
regulated O
compared O
with O
that O
in O
adjacent O
normal O
tissues O
. O

Moreover O
, O
overexpression O
of O
lncRNA O
MORT B-RNA
inhibits O
migration O
and O
invasion O
of O
colon B-Disease
cancer I-Disease
cells O
by O
inhibiting O
TGF O
- O
β O
protein O
expression O
. O

lncUSMycN B-RNA
knockdown O
induced O
apoptosis O
and O
suppressed O
cellular O
migration O
in O
breast B-Disease
cancer I-Disease
cells O
. O

The O
current O
study O
identified O
that O
circSCYL2 O
was O
downregulated O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
, O
and O
that O
circSCYL2 O
overexpression O
inhibited O
cell O
migration O
and O
invasion O
. O

The O
circRHOT1 B-RNA
may O
play O
a O
role O
in O
pancreatic B-Disease
cancer I-Disease
through O
binding O
miR B-RNA
- I-RNA
26b I-RNA
, O
miR B-RNA
- I-RNA
125a I-RNA
, O
miR B-RNA
- I-RNA
330 I-RNA
and O
miR B-RNA
- I-RNA
382 I-RNA
to O
regulate O
multiple O
tumor O
- O
associated O
pathways O
. O

Additional O
GWAS O
identified O
ANRIL B-RNA
as O
a O
risk O
locus O
for O
several O
cancers O
including O
breast B-Disease
cancer I-Disease
, O
nasopharyngeal B-Disease
carcinoma I-Disease
, O
basal B-Disease
cell I-Disease
carcinoma I-Disease
, O
and O
glioma B-Disease
. O

TCGA O
analysis O
showed O
lncRNA O
SNHG3 B-RNA
was O
not O
only O
related O
to O
ovarian B-Disease
cancer I-Disease
survival O
, O
but O
also O
energy O
metabolism O
. O

Taken O
together O
, O
these O
findings O
demonstrate O
that O
pseudogene O
- O
derived O
long O
noncoding O
RNA O
SFTA1P B-RNA
exerts O
the O
tumor O
suppressor O
functions O
in O
human O
lung B-Disease
adenocarcinoma I-Disease
. O

This O
study O
not O
only O
provides O
novel O
insights O
into O
the O
molecular O
mechanism O
of O
SNHG1 B-RNA
in O
the O
progression O
of O
ischemic B-Disease
stroke I-Disease
, O
but O
also O
supplies O
further O
understanding O
of O
the O
function O
of O
lncRs O
in O
the O
pathogenesis O
of O
ischemic B-Disease
stroke I-Disease
. O

Thus O
, O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
positively O
regulated O
the O
expression O
of O
EZH2 O
through O
sponging O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
3p I-RNA
, O
and O
played O
an O
oncogenic O
role O
in O
bladder B-Disease
cancer I-Disease
progression O
. O

In O
summary O
, O
the O
present O
study O
reported O
that O
knockdown O
of O
SOX2 B-RNA
- I-RNA
OT I-RNA
could O
suppress O
cell O
proliferation O
, O
migration O
and O
invasion O
, O
and O
induce O
apoptosis O
in O
laryngeal B-Disease
cancer I-Disease
by O
targeting O
miR B-RNA
- I-RNA
654 I-RNA
. O

Additionally O
, O
knockdown O
of O
SNHG7 B-RNA
significantly O
inhibited O
thyroid B-Disease
cancer I-Disease
cell O
proliferation O
and O
cell O
cycle O
progression O
in O
vitro O
. O

MiR B-RNA
- I-RNA
98 I-RNA
- I-RNA
5p I-RNA
inhibition O
abrogated O
the O
effect O
of O
SNHG4 O
silencing O
on O
proliferation O
and O
invasion O
of O
lung B-Disease
cancer I-Disease
cells O
. O

SNHG3 B-RNA
serves O
as O
an O
independent O
risk O
factor O
for O
poor O
prognosis O
of O
osteosarcoma B-Disease
. O

Knockdown O
of O
SNHG16 B-RNA
inhibits O
the O
viability O
and O
induces O
apoptosis O
of O
glioma B-Disease
cells O
. O

Functional O
studies O
demonstrated O
that O
knockdown O
of O
SNHG16 B-RNA
suppressed O
retinoblastoma B-Disease
cell O
migration O
and O
invasion O
. O

SNHG16 B-RNA
inhibition O
reduced O
the O
proliferation O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O
in O
vitro O
. O

SNHG16 B-RNA
expression O
was O
significantly O
increased O
in O
ovarian B-Disease
cancer I-Disease
, O
and O
was O
correlated O
with O
ovarian B-Disease
cancer I-Disease
staging O
, O
distant O
metastasis O
and O
poor O
prognosis O
. O

Therefore O
, O
we O
suggest O
that O
SNHG15 B-RNA
and O
miR B-RNA
- I-RNA
153 I-RNA
are O
novel O
targets O
for O
glioma B-Disease
anti O
- O
angiogenesis O
therapy O
. O

The O
in O
vitro O
studies O
suggested O
SNHG15 B-RNA
overexpression O
suppressed O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
in O
thyroid B-Disease
cancer I-Disease
. O

In O
summary O
, O
SNHG15 B-RNA
serves O
as O
tumor O
suppressive O
role O
in O
thyroid B-Disease
cancer I-Disease
. O

SNHG1 B-RNA
was O
a O
valuable O
cancer O
- O
related O
lncR O
that O
the O
expression O
level O
was O
up O
- O
regulation O
in O
a O
variety O
of O
maligncies O
, O
including O
glioma B-Disease
, O
esophageal B-Disease
cancer I-Disease
, O
lung B-Disease
cancer I-Disease
, O
gastric B-Disease
cancer I-Disease
, O
hepatocellular B-Disease
carcinoma I-Disease
, O
colorectal B-Disease
carcinoma I-Disease
, O
prostate B-Disease
cancer I-Disease
, O
cervical B-Disease
cancer I-Disease
, O
osteosarcoma B-Disease
, O
neuroblastoma B-Disease
, O
sopharyngeal B-Disease
carcinoma I-Disease
. O

Silencing O
of O
LINK B-RNA
- I-RNA
A I-RNA
led O
to O
inhibition O
of O
pancreatic B-Disease
adenocarcinoma I-Disease
cell O
proliferation O
, O
migration O
and O
invasion O
. O

Several O
lncRNAs O
, O
including O
BANCR B-RNA
, O
AFAP1 B-RNA
- I-RNA
AS1 I-RNA
, O
NEAT1 B-RNA
, O
XIST B-RNA
, O
ANRIL B-RNA
, O
PlncRNA B-RNA
- I-RNA
1 I-RNA
, O
HOTAIR B-RNA
, O
PANDAR B-RNA
, O
DANCR B-RNA
, O
and O
THOR B-RNA
, O
promote O
the O
progression O
and O
metastasis O
of O
retinoblastoma B-Disease
. O

Rpph1 B-RNA
was O
highly O
expressed O
in O
esophageal B-Disease
carcinoma I-Disease
, O
making O
it O
a O
promising O
marker O
for O
the O
diagnosis O
of O
esophageal B-Disease
cancer I-Disease
. O

Our O
findings O
indicate O
that O
long O
noncoding O
RNA O
RP11 B-RNA
- I-RNA
3.34E+08 I-RNA
. I-RNA
12 I-RNA
promotes O
the O
proliferation O
, O
migration O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O
by O
activating O
the O
STAT3 O
pathway O
. O

ROR1 B-RNA
- I-RNA
AS1 I-RNA
is O
highly O
expressed O
either O
in O
colon B-Disease
cancer I-Disease
tissues O
or O
in O
cell O
lines O
, O
which O
is O
able O
to O
enhance O
cell O
proliferation O
, O
accelerate O
cell O
cycle O
, O
and O
inhibit O
cell O
apoptosis O
. O

Role O
of O
long O
noncoding O
RNA O
ZFAS1 B-RNA
in O
proliferation O
, O
apoptosis O
and O
migration O
of O
chondrocytes O
in O
osteoarthritis B-Disease
. O

The O
findings O
of O
this O
study O
suggested O
that O
the O
down O
- O
regulation O
of O
DUXAP10 B-RNA
expression O
suppressed O
the O
progression O
of O
prostate B-Disease
cancer I-Disease
by O
inhibiting O
cell O
proliferation O
, O
migration O
and O
promote O
cell O
apoptosis O
. O

In O
clinical O
samples O
, O
the O
level O
of O
LINC01116 B-RNA
in O
patients O
with O
breast B-Disease
cancer I-Disease
was O
significantly O
increased O
, O
which O
was O
correlated O
with O
the O
overall O
survival O
, O
tumor O
size O
and O
tumor O
node O
metastasis O
( O
TNM O
) O
stage O
in O
patients O
, O
but O
not O
correlated O
with O
the O
age O
, O
sex O
and O
lymph O
node O
metastasis O
( O
p O
> O
0 O
. O
5 O
) O
. O

Results O
of O
functional O
assays O
revealed O
the O
oncogenic O
function O
of O
KCNQ1OT O
in O
cholangiocarcinoma B-Disease
progression O
. O

Results O
indicate O
that O
in O
ATRTs O
, O
medulloblastomas B-Disease
, O
and O
juvenile O
pilocytic O
astrocytomas B-Disease
( O
JPAs O
) O
, O
the O
HOTAIR B-RNA
and O
HOXC B-RNA
genes O
are O
highly O
expressed O
, O
however O
, O
HOXD8 B-RNA
- I-RNA
10 I-RNA
genes O
are O
not O
silenced O
. O

Reduced O
expression O
of O
MNX1 B-RNA
- I-RNA
AS1 I-RNA
could O
suppress O
cell O
proliferation O
, O
migration O
, O
invasion O
, O
and O
epithelial O
- O
mesenchymal O
transition O
in O
bladder B-Disease
cancer I-Disease
cells O
, O
whereas O
overexpression O
of O
MNX1 B-RNA
- I-RNA
AS1 I-RNA
resulted O
in O
the O
opposite O
effects O
. O

it O
indicated O
that O
the O
expression O
of O
EBIC B-RNA
was O
negatively O
correlated O
with O
the O
survival O
time O
of O
patients O
with O
ovarian B-Disease
cancer I-Disease
. O

qRT O
- O
PCR O
showed O
that O
circGFRA1 B-RNA
was O
overexpressed O
in O
ovarian B-Disease
cancer I-Disease
tissues O
. O

Inhibition O
of O
circGFRA1 B-RNA
suppressed O
cell O
proliferation O
and O
invasion O
, O
but O
induced O
cell O
apoptosis O
in O
ovarian B-Disease
cancer I-Disease
. O

PVT1 B-RNA
was O
the O
most O
amplifed O
gene O
in O
ovarian B-Disease
cancer I-Disease
patients O
, O
and O
it O
was O
highly O
correlated O
with O
poor O
survival O
outcomes O
. O

PILRLS B-RNA
, O
which O
as O
an O
oncogene O
significantly O
overexpressed O
in O
retroperitoneal B-Disease
liposarcoma I-Disease
. O

Functionally O
, O
loss O
of O
circSMC3 O
abolished O
the O
proliferation O
and O
motility O
of O
gastric B-Disease
cancer I-Disease
cells O
. O

Mechanically O
, O
circSMC3 O
decreased O
miR B-RNA
- I-RNA
4720 I-RNA
- I-RNA
3p I-RNA
expression O
by O
acting O
as O
a O
miRNA O
sponge O

knockdown O
of O
miR B-RNA
- I-RNA
133a I-RNA
exhibited O
the O
opposite O
effect O
, O
which O
revealed O
that O
miR B-RNA
- I-RNA
133a I-RNA
negatively O
regulates O
glioma B-Disease
progression O
. O

Overexpression O
of O
lncRNA O
EGFR B-RNA
- I-RNA
AS1 I-RNA
is O
associated O
with O
a O
poor O
prognosis O
and O
promotes O
chemotherapy O
resistance O
in O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
. O

Overexpression O
of O
lncRNA O
CASC2 B-RNA
significantly O
repressed O
proliferation O
and O
metastasis O
while O
caused O
cell O
cycle O
arrest O
and O
much O
more O
early O
apoptosis O
of O
breast B-Disease
cancer I-Disease
. O

Overexpression O
of O
LncRNA O
AFAP1 B-RNA
- I-RNA
AS1 I-RNA
predicts O
poor O
prognosis O
and O
promotes O
cells O
proliferation O
and O
invasion O
in O
gallbladder B-Disease
cancer I-Disease
. O

Overall O
, O
our O
study O
showed O
that O
LINC00909 B-RNA
could O
act O
as O
an O
oncogenic O
lncRNA O
in O
glioma B-Disease
tumorigenesis O
. O

Our O
studies O
have O
suggested O
that O
linc B-RNA
- I-RNA
ROR I-RNA
, O
a O
critical O
factor O
for O
embryonic O
stem O
cell O
maintenance O
, O
probably O
acts O
as O
an O
oncogenic O
factor O
in O
breast B-Disease
cancer I-Disease
cells O
, O
causing O
poor O
prognostic O
outcomes O
. O

Our O
results O
suggest O
that O
linc B-RNA
- I-RNA
MAF I-RNA
- I-RNA
4 I-RNA
is O
involved O
in O
the O
pathogenesis O
of O
MS O
, O
specifically O
via O
regulation O
of O
encephalitogenic O
T O
cells O
. O

Linc O
- O
MAF O
- O
4 O
regulates O
Th1 O
/ O
Th2 O
differentiation O
and O
is O
associated O
with O
the O
pathogenesis O
of O
multiple B-Disease
sclerosis I-Disease
by O
targeting O
MAF O
. O

Our O
results O
showed O
that O
expression O
of O
HOTAIR B-RNA
was O
significantly O
upregulated O
in O
cervical B-Disease
cancer I-Disease
cells O
and O
inhibition O
of O
the O
expression O
of O
HOTAIR B-RNA
in O
HeLa O
cervical B-Disease
cancer I-Disease
cells O
resulted O
in O
suppression O
of O
cell O
proliferation O
, O
migration O
and O
invasion O
. O

In O
conclusion O
, O
our O
data O
suggest O
that O
MAGI2 B-RNA
- I-RNA
AS3 I-RNA
expression O
is O
decreased O
in O
breast B-Disease
cancer I-Disease
and O
that O
MAGI2 B-RNA
- I-RNA
AS3 I-RNA
plays O
an O
important O
role O
as O
a O
tumour O
suppressor O
by O
targeting O
Fas O
and O
FasL O
signalling O
. O

These O
results O
provide O
novel O
insight O
into O
breast B-Disease
cancer I-Disease
tumorigenesis O
and O
suggest O
that O
SNHG16 B-RNA
could O
serve O
as O
a O
therapeutic O
target O
in O
breast B-Disease
cancer I-Disease
. O

SNHG20 B-RNA
promoted O
osteosarcoma B-Disease
cell O
migration O
and O
invasion O
through O
modulating O
epithelial O
- O
mesenchymal O
transition O
- O
associated O
genes O
. O

Our O
results O
indicate O
that O
XIST B-RNA
acts O
as O
a O
miR B-RNA
- I-RNA
146a I-RNA
sponge O
to O
promote O
the O
expression O
of O
miR B-RNA
- I-RNA
146a I-RNA
target O
gene O
Nav1 O
. O
7 O
to O
regulate O
DRG O
SGC O
activation O
and O
inflammatory B-Disease
pain I-Disease
. O

Our O
findings O
revealed O
that O
the O
upregulated O
CCAT1 B-RNA
results O
in O
significantly O
enhancing O
paclitaxel O
resistance O
in O
nasopharyngeal B-Disease
cancer I-Disease
cells O
. O

This O
study O
suggests O
SNHG1 B-RNA
as O
potential O
novel O
therapeutic O
target O
for O
Lung O
squamous O
cell O
carcinoma O
. O

Our O
data O
showed O
that O
the O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
75341 I-RNA
was O
significantly O
upregulated O
and O
associated O
with O
larger O
tumor O
size O
, O
advanced O
FIGO O
stage O
, O
and O
lymph O
- O
node O
metastasis O
in O
cervical B-Disease
cancer I-Disease
patients O
. O

Our O
data O
revealed O
that O
MALAT1 O
inhibited O
tongue B-Disease
cancer I-Disease
cell O
growth O
and O
metastasis O
through O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
124 I-RNA
- O
dependent O
JAG1 O
regulation O
. O

Liu O
J O
et O
al O
showed O
that O
SNHG20 O
played O
an O
oncogenic O
role O
in O
liver B-Disease
cancer I-Disease
, O
and O
promoted O
the O
EMT O
pathway O
in O
cancer O
progression O
. O

Furthermore O
, O
univariate O
and O
multivariate O
analysis O
showed O
that O
higher O
CRALA B-RNA
expression O
was O
significantly O
associated O
with O
poor O
prognosis O
in O
144 O
breast B-Disease
cancer I-Disease
patients O
. O

Overexpression O
of O
SNHG9 B-RNA
in O
glioblastoma B-Disease
cells O
promoted O
aerobic O
glycolysis O
and O
cell O
proliferation O
, O
which O
could O
be O
attenuated O
by O
miR B-RNA
- I-RNA
199a I-RNA
- I-RNA
5p I-RNA
. O

Moreover O
, O
our O
results O
indicated O
that O
NKILA B-RNA
inhibited O
the O
carcinogenesis O
of O
melanoma B-Disease
cells O
through O
the O
inhibition O
of O
NF O
- O
κ O
Bin O
vitro O
. O

The O
survival O
analyses O
showed O
that O
patients O
with O
osteosarcoma B-Disease
with O
high O
expression O
of O
TP73 B-RNA
- I-RNA
AS1 I-RNA
obviously O
had O
lower O
overall O
survival O
than O
osteosarcoma B-Disease
patients O
with O
low O
expression O
of O
TP73 B-RNA
- I-RNA
AS1 I-RNA
, O
and O
high O
expression O
of O
TP73 B-RNA
- I-RNA
AS1 I-RNA
was O
an O
independent O
poor O
prognostic O
factor O
for O
osteosarcoma B-Disease
patients O
. O

Moreover O
, O
knockdown O
/ O
overexpression O
of O
MNX1 B-RNA
- I-RNA
AS1 I-RNA
inhibits O
/ O
promotes O
proliferation O
, O
migration O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O
. O

In O
the O
survival O
analysis O
, O
we O
observed O
that O
triple B-Disease
- I-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
patients O
with O
low O
MIR503HG B-RNA
expression O
had O
a O
statistically O
significant O
worse O
prognosis O
compared O
with O
those O
with O
high O
MIR503HG B-RNA
expression O
, O
and O
low O
MIR503HG B-RNA
expression O
was O
a O
poor O
independent O
prognostic O
factor O
for O
overall O
survival O
in O
triple B-Disease
- I-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
patients O
. O

Depletion O
of O
MCM3AP B-RNA
- I-RNA
AS1 I-RNA
repressed O
cell O
proliferation O
, O
migration O
, O
and O
angiogenesis O
in O
lung O
cancer O
cells O

MATN1 B-RNA
- I-RNA
AS1 I-RNA
upregulation O
confirmed O
in O
glioma O
predicted O
poor O
clinical O
outcomes O
. O

Functionally O
, O
MATN1 B-RNA
- I-RNA
AS1 I-RNA
knockdown O
restrained O
cell O
proliferation O
but O
stimulated O
apoptosis O
in O
vitro O
and O
repressed O
tumour O
growth O
in O
vivo O
. O

The O
lncRNA O
LUCAT1 B-RNA
was O
critical O
for O
the O
proliferation O
and O
invasion O
of O
glioma B-Disease
cells O
by O
regulating O
miR B-RNA
- I-RNA
375 I-RNA
. O

Further O
investigation O
showed O
that O
silencing O
LOXL1 B-RNA
- I-RNA
AS1 I-RNA
inhibited O
proliferation O
, O
promoted O
cell O
apoptosis O
and O
decreased O
the O
capacity O
of O
cell O
migrated O
and O
invasive O
in O
breast B-Disease
cancer I-Disease
cells O
. O

MEG3 B-RNA
overexpression O
inhibited O
endometrial B-Disease
cancer I-Disease
cell O
proliferation O
, O
invasion O
, O
and O
metastasis O
; O
promoted O
apoptosis O
; O
and O
inhibited O
the O
activation O
of O
the O
phosphoinositide O
3 O
- O
kinase O
( O
PI3K O
) O
/ O
m O
- O
TOR O
signaling O
pathway O
. O

Long O
non O
- O
coding O
RNA O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
promotes O
cell O
invasion O
and O
epithelial O
to O
mesenchymal O
transition O
through O
inducing O
ZEB1 O
expression O
in O
cervical B-Disease
cancer I-Disease
. O
we O
found O
that O
knockdown O
of O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
significantly O
inhibited O
ZEB1 O
expression O
. O

Long O
non O
- O
coding O
RNA O
TUSC7 B-RNA
inhibits O
temozolomide O
resistance O
by O
targeting O
miR B-RNA
- I-RNA
10a I-RNA
in O
glioblastoma B-Disease
. O

Long O
noncoding O
RNA O
TMEM75 B-RNA
promotes O
colorectal B-Disease
cancer I-Disease
progression O
by O
activation O
of O
SIM2 O
. O

Long O
noncoding O
RNA O
PVT1 B-RNA
promotes O
laryngeal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
development O
by O
acting O
as O
a O
molecular O
sponge O
to O
regulate O
miR B-RNA
- I-RNA
519d I-RNA
- I-RNA
3p I-RNA
. O

Our O
results O
suggest O
that O
PVT1 B-RNA
could O
promote O
metastasis O
and O
proliferation O
of O
colon B-Disease
cancer I-Disease
via O
endogenous O
sponging O
and O
inhibiting O
the O
expression O
of O
miR B-RNA
- I-RNA
26b I-RNA
, O
which O
may O
highlight O
the O
significance O
of O
lncRNA O
PVT1 B-RNA
in O
colon B-Disease
cancer I-Disease
tumorigenesis O
. O

Long O
non O
- O
coding O
RNA O
NORAD B-RNA
upregulate O
SIP1 O
expression O
to O
promote O
cell O
proliferation O
and O
invasion O
in O
cervical B-Disease
cancer I-Disease
. O

Long O
non O
- O
coding O
RNA O
MSTO2P B-RNA
promotes O
the O
proliferation O
and O
colony O
formation O
in O
gastric B-Disease
cancer I-Disease
by O
indirectly O
regulating O
miR B-RNA
- I-RNA
335 I-RNA
expression O
. O

Long O
Noncoding O
RNA O
MEG3 B-RNA
Inhibits O
Cell O
Proliferation O
and O
Metastasis O
in O
Chronic O
Myeloid O
Leukemia O
via O
Targeting O
miR B-RNA
- I-RNA
184 I-RNA
. O

Long O
noncoding O
RNA O
MEG3 B-RNA
activation O
of O
p53 O
mediates O
ischemic O
neuronal O
death O
in O
stroke B-Disease

Long O
non O
- O
coding O
RNA O
LINC00672 B-RNA
contributes O
to O
p53 O
protein O
- O
mediated O
gene O
suppression O
and O
promotes O
endometrial B-Disease
cancer I-Disease
chemosensitivity O
. O

Long O
Noncoding O
RNA O
LINC00261 B-RNA
Suppresses O
Cell O
Proliferation O
and O
Invasion O
and O
Promotes O
Cell O
Apoptosis O
in O
Human O
Choriocarcinoma O
. O

Long O
non O
- O
coding O
RNA O
HOTTIP B-RNA
is O
upregulation O
in O
renal B-Disease
cell I-Disease
carcinoma I-Disease
and O
regulates O
cell O
growth O
and O
apoptosis O
by O
epigenetically O
silencing O
of O
LATS2 O
. O

Long O
noncoding O
RNA O
HOTTIP B-RNA
is O
a O
significant O
indicator O
of O
ovarian B-Disease
cancer I-Disease
prognosis O
and O
enhances O
cell O
proliferation O
and O
invasion O
. O

Long O
non O
- O
coding O
RNA O
FTH1P3 B-RNA
facilitates O
uveal B-Disease
melanoma I-Disease
cell O
growth O
and O
invasion O
through O
miR B-RNA
- I-RNA
224 I-RNA
- I-RNA
5p I-RNA
; O
Elevated O
expression O
of O
FTH1P3 B-RNA
enhanced O
uveal B-Disease
melanoma I-Disease
cell O
proliferation O
and O
migration O
by O
inhibiting O
miR B-RNA
- I-RNA
224 I-RNA
- I-RNA
5p I-RNA
expression O
. O

Long O
non O
- O
coding O
RNA O
EPIC1 O
promotes O
human O
lung B-Disease
cancer I-Disease
cell O
growth O
. O

Together O
, O
our O
results O
show O
that O
Lnc B-RNA
- I-RNA
EPIC1 I-RNA
promotes O
human O
lung B-Disease
cancer I-Disease
cell O
growth O
possibly O
by O
targeting O
MYC O
. O

Long O
non O
- O
coding O
RNA O
EPIC1 O
promotes O
cholangiocarcinoma B-Disease
cell O
growth O
. O

Long O
noncoding O
RNA O
DGCR5 B-RNA
represses O
hepatocellular B-Disease
carcinoma I-Disease
progression O
by O
inactivating O
Wnt O
signaling O
pathway O
. O

Long O
noncoding O
RNA O
CCAT1 B-RNA
acts O
as O
an O
oncogene O
and O
promotes O
chemoresistance O
in O
docetaxel O
- O
resistant O
lung B-Disease
adenocarcinoma I-Disease
cells O
. O

After O
the O
expression O
of O
lncRNA O
- O
SNHG7 B-RNA
was O
downregulated O
, O
the O
proliferation O
of O
bladder B-Disease
cancer I-Disease
cells O
was O
decreased O
, O
the O
apoptosis O
was O
increased O
, O
and O
the O
invasion O
ability O
of O
cells O
was O
decreased O
. O

lncRNA O
- O
SNHG7 B-RNA
was O
overexpressed O
in O
prostate B-Disease
cancer I-Disease
tissues O
, O
and O
it O
might O
contributes O
to O
the O
development O
and O
progression O
of O
prostate B-Disease
cancer I-Disease
. O

lncRNA O
- O
SNHG7 B-RNA
promotes O
the O
proliferation O
, O
migration O
and O
invasion O
and O
inhibits O
apoptosis O
of O
lung B-Disease
cancer I-Disease
cells O
by O
enhancing O
the O
FAIM2 O
expression O
. O

LncRNA O
ZEB1 B-RNA
- I-RNA
AS1 I-RNA
is O
highly O
expressed O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cells O
, O
and O
it O
is O
expected O
to O
be O
a O
new O
prognostic O
marker O
of O
gastric B-Disease
cancer I-Disease
used O
for O
the O
clinical O
diagnosis O
and O
prognostic O
evaluation O
. O

Collectively O
, O
the O
study O
indicates O
that O
linc01023 O
plays O
an O
oncogenic O
role O
in O
glioma B-Disease
through O
activation O
of O
IGF1R O
/ O
AKT O
signal O
pathway O
, O
and O
it O
could O
be O
a O
candidate O
therapeutic O
target O
. O

LINC00310 B-RNA
was O
increased O
as O
breast B-Disease
cancer I-Disease
progressed O
, O
and O
the O
deregulation O
of O
LINC00310 B-RNA
was O
significantly O
associated O
with O
patients O
' O
survival O
. O

LINC00261 B-RNA
suppresses O
cell O
proliferation O
, O
invasion O
and O
Notch O
signaling O
pathway O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Knock O
- O
down O
of O
Linc00483 O
inhibited O
cervical B-Disease
cancer I-Disease
cell O
proliferation O
, O
invasion O
as O
well O
as O
migration O
, O
and O
promoted O
cell O
apoptosis O
. O

Knockdown O
of O
LINC00339 B-RNA
inhibited O
glioma B-Disease
cell O
proliferation O
, O
migration O
, O
invasion O
, O
and O
tube O
formation O
, O
meanwhile O
downregulating O
the O
expression O
of O
VM O
- O
related O
molecular O
MMP O
- O
2 O
and O
MMP O
- O
14 O
. O

Increased O
expression O
of O
lncRNA O
- O
NORAD B-RNA
in O
breast B-Disease
cancer I-Disease
tissues O
promotes O
proliferation O
, O
invasion O
and O
migration O
of O
breast B-Disease
cancer I-Disease
cells O
and O
correlated O
with O
worse O
prognosis O
. O

Increased O
expression O
of O
LNAPPCC B-RNA
is O
positively O
associated O
with O
metastasis O
, O
recurrence O
, O
and O
poor O
survival O
of O
colon B-Disease
cancer I-Disease
patients O
. O

Increased O
expression O
of O
LINC01510 B-RNA
predicts O
poor O
prognosis O
and O
promotes O
malignant O
progression O
in O
human O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
. O

Increased O
expression O
of O
antisense O
lncRNA O
SPINT1 B-RNA
- I-RNA
AS1 I-RNA
predicts O
a O
poor O
prognosis O
in O
colorectal B-Disease
cancer I-Disease
and O
is O
negatively O
correlated O
with O
its O
sense O
transcript O
. O

In O
this O
study O
, O
we O
show O
that O
overexpression O
of O
the O
long O
noncoding O
RNA O
LNMICC B-RNA
associates O
with O
lymph O
node O
metastasis O
of O
primary O
cervical B-Disease
cancer I-Disease
, O
where O
it O
serves O
as O
an O
independent O
high O
- O
risk O
factor O
in O
patient O
survival O
. O

In O
this O
study O
, O
we O
observed O
that O
TINCR B-RNA
was O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
and O
contributed O
to O
oncogenesis O
and O
cancer O
progression O
. O

In O
the O
present O
study O
, O
we O
found O
that O
TUG1 B-RNA
expression O
was O
upregulated O
in O
cervical B-Disease
cancer I-Disease
tissues O
and O
correlated O
with O
advanced O
clinical O
features O
and O
poor O
overall O
survival O
. O

In O
addition O
, O
lncRNA O
SNHG20 B-RNA
knockdown O
suppressed O
the O
ovarian B-Disease
cancer I-Disease
progression O
, O
whereas O
overexpression O
of O
SNHG20 B-RNA
showed O
the O
opposite O
effects O
. O

In O
the O
present O
study O
, O
we O
found O
that O
circSLC8A1 B-RNA
was O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
, O
and O
circSLC8A1 B-RNA
expression O
was O
associated O
with O
the O
pathological O
stage O
and O
histological O
grade O
of O
bladder B-Disease
cancer I-Disease
. O

In O
the O
present O
study O
, O
we O
demonstrated O
small O
nucleolar O
RNA O
host O
gene O
16 O
( O
SNHG16 B-RNA
) O
as O
an O
oncogene O
on O
cell O
migration O
in O
breast B-Disease
cancer I-Disease
. O

Up O
- O
regulation O
of O
lncRNA O
Dleu2 B-RNA
may O
be O
one O
of O
the O
targets O
of O
inhibiting O
laryngeal B-Disease
cancer I-Disease
growth O
and O
metastasis O
. O

Our O
findings O
shed O
light O
on O
potential O
therapeutic O
strategies O
by O
targeting O
oncogenic O
lncR O
SNHG15 B-RNA
in O
colon B-Disease
cancer I-Disease
patients O
. O

This O
study O
identified O
GAS5 B-RNA
as O
a O
critical O
regulator O
in O
hypoxia B-Disease
response O
of O
PC O
- O
12 O
cells O
and O
might O
provide O
the O
potential O
of O
gene O
therapy O
for O
treating O
cerebral O
ischemia O
. O

LncRNA O
SOX2 B-RNA
- I-RNA
OT I-RNA
regulated O
osteosarcoma B-Disease
cells O
proliferation O
, O
migration O
, O
invasion O
, O
and O
expression O
of O
cancer O
stem O
cell O
biomarkers O
. O

Taken O
together O
, O
our O
data O
indicated O
that O
CCAL B-RNA
promoted O
papillary B-Disease
thyroid I-Disease
cancer I-Disease
development O
and O
progression O
by O
activation O
of O
NOTCH1 O
pathway O
, O
which O
provided O
a O
new O
insight O
on O
the O
design O
of O
therapeutic O
targets O
. O

In O
conclusion O
, O
we O
found O
that O
SNHG12 B-RNA
could O
promote O
the O
angiogenesis O
and O
alleviate O
ischemic B-Disease
stroke I-Disease
. O

In O
conclusion O
, O
the O
present O
study O
presents O
that O
MEG3 B-RNA
is O
significantly O
downregulated O
in O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
tissues O
and O
exerts O
tumor O
- O
suppressive O
functions O
. O

In O
conclusion O
, O
the O
present O
study O
for O
the O
first O
time O
revealed O
that O
lncRNA O
- O
PRLB B-RNA
was O
upregulated O
in O
breast B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
, O
and O
higher O
levels O
of O
lncRNAPRLB O
were O
associated O
with O
tumor O
progression O
and O
inversely O
correlated O
with O
prognosis O
. O

These O
results O
support O
a O
promising O
role O
of O
SNHG1 B-RNA
in O
the O
treatment O
of O
patients O
with O
breast B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
SNHG20 B-RNA
expression O
is O
increased O
in O
osteosarcoma B-Disease
, O
and O
associated O
with O
clinical O
progression O
and O
unfavorable O
prognosis O
. O

Furthermore O
, O
RNCR3 B-RNA
promote O
cell O
proliferation O
, O
colony O
formation O
, O
and O
invasion O
of O
prostate B-Disease
cancer I-Disease
cells O
by O
binding O
to O
and O
suppressing O
miR O
- O
185 O
- O
5p O
. O

In O
conclusion O
, O
our O
study O
showed O
that O
the O
upregulation O
of O
linc O
- O
UFC1 B-RNA
in O
cervical B-Disease
cancer I-Disease
tissues O
was O
closely O
correlated O
with O
malignant O
clinical O
features O
and O
poor O
prognosis O
of O
patients O
with O
cervical B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
our O
study O
identifies O
LINC01355 B-RNA
as O
a O
novel O
tumor O
suppressor O
. O

Downregulation O
of O
LINC01355 B-RNA
contributes O
to O
aggressive O
phenotype O
of O
breast B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
our O
data O
indicate O
that O
circ B-RNA
- I-RNA
LDLRAD3 I-RNA
expression O
was O
significantly O
up O
- O
regulated O
in O
pancreatic B-Disease
cancer I-Disease
cell O
lines O
, O
pancreatic B-Disease
cancer I-Disease
tissues O
, O
and O
pancreatic B-Disease
cancer I-Disease
plasma O
samples O
. O

In O
conclusion O
, O
lncRNA16 O
was O
identified O
as O
a O
potential O
biomarker O
for O
lung B-Disease
cancer I-Disease
diagnosis O
, O
as O
it O
displayed O
significantly O
elevated O
levels O
over O
the O
baseline O
in O
patients O
with O
lung O
patient O
. O

In O
conclusion O
, O
in O
this O
study O
, O
and O
to O
the O
best O
of O
our O
knowledge O
, O
we O
report O
for O
the O
first O
time O
that O
circRNA B-RNA
- I-RNA
911 I-RNA
plays O
an O
anti O
- O
oncogenic O
role O
in O
breast B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
for O
the O
first O
time O
, O
we O
found O
that O
HOTTIP O
expression O
is O
decreased O
in O
ischemic B-Disease
stroke I-Disease
models O
. O

Thus O
, O
inhibition O
of O
Erbb4 B-RNA
- I-RNA
IR I-RNA
may O
represent O
a O
novel O
and O
precise O
therapeutic O
strategy O
for O
renal B-Disease
fibrosis I-Disease
. O

In O
addition O
, O
low O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
8225 I-RNA
expression O
was O
associated O
with O
poor O
overall O
survival O
in O
patients O
with O
glioma B-Disease
. O

Further O
, O
in O
vitro O
studies O
showed O
that O
knockdown O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
13958 I-RNA
suppressed O
proliferation O
, O
migration O
, O
and O
invasion O
of O
ovarian B-Disease
cancer I-Disease
cells O
but O
elevated O
the O
cell O
apoptotic O
rate O
. O

hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
7843 I-RNA
was O
also O
found O
to O
be O
highly O
expressed O
in O
colon B-Disease
cancer I-Disease
SW480 O
cells O
. O

Overexpression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
7843 I-RNA
promoted O
the O
invasion O
and O
migration O
of O
SW480 O
cells O
, O
whereas O
its O
downregulation O
suppressed O
their O
invasion O
and O
migration O
. O

HRCEG B-RNA
might O
inhibit O
gastric B-Disease
cancer I-Disease
progress O
by O
regulating O
cell O
proliferation O
and O
apoptosis O
. O
HRCEG B-RNA
suppresses O
EMT O
process O
in O
gastric B-Disease
cancer I-Disease
cells O
. O

Highly O
expressed O
in O
the O
tissues O
and O
serum O
of O
pancreatic B-Disease
cancer I-Disease
patients O
, O
HULC B-RNA
showed O
good O
clinical O
value O
in O
distinguishing O
between O
patients O
with O
pancreatic B-Disease
cancer I-Disease
, O
patients O
with O
benign O
pancreatic O
diseases O
and O
healthy O
subjects O
. O

High O
expression O
of O
NEAT1 B-RNA
predicted O
poor O
prognosis O
of O
cervical B-Disease
cancer I-Disease
patients O
. O
high O
level O
of O
NEAT1 B-RNA
expression O
was O
signifcantly O
correlated O
with O
lymph O
node O
metastasis O
. O

Here O
, O
we O
performed O
unbiased O
screening O
of O
lncRNAs O
in O
liver B-Disease
tumorigenesis I-Disease
and O
found O
lncTIC1 B-RNA
was O
highly O
expressed O
with O
liver B-Disease
tumorigenesis I-Disease
. O

Here O
we O
found O
long O
noncoding O
RNA O
SAMMSON B-RNA
is O
highly O
expressed O
in O
liver B-Disease
cancer I-Disease
and O
liver O
TICs O
. O

H19 B-RNA
expression O
was O
elevated O
in O
cervical B-Disease
cancer I-Disease
cell O
lines O
and O
could O
be O
detected O
in O
extracellular O
vesicles O
in O
the O
culture O
medium O
. O

Taken O
together O
, O
we O
conclude O
that O
SNHG20 B-RNA
over O
- O
expression O
promotes O
the O
progression O
of O
ovarian B-Disease
cancer I-Disease
. O

Taken O
together O
, O
our O
results O
proved O
that O
lncRNA O
- O
CDC6 B-RNA
could O
function O
as O
ceRNA O
and O
promote O
the O
proliferation O
and O
metastasis O
of O
breast B-Disease
cancer I-Disease
cells O
, O
which O
provided O
a O
novel O
prognostic O
marker O
for O
breast O
cancers O
in O
clinic O
. O

Function O
assay O
showed O
that O
HOXA11 B-RNA
- I-RNA
AS I-RNA
inhibition O
significantly O
suppressed O
renal B-Disease
cancer I-Disease
cells O
growth O
, O
invasion O
, O
and O
ETM O
phenotype O
. O

FOXD3 B-RNA
- I-RNA
AS1 I-RNA
has O
significantly O
high O
expression O
in O
breast B-Disease
cancer I-Disease
tumour O
comparing O
with O
the O
normal O
tissue O
. O

Conversely O
, O
DANCR B-RNA
knockdown O
inhibits O
cervical B-Disease
cancer I-Disease
cell O
proliferation O
in O
vitro O
and O
xenograft O
growth O
in O
vivo O
. O

Downregulation O
of O
HAND2 B-RNA
- I-RNA
AS1 I-RNA
was O
detected O
in O
breast B-Disease
cancer I-Disease
and O
was O
associated O
with O
adverse O
clinical O
features O
and O
prognosis O
. O

Downregulation O
of O
DLEU1 B-RNA
in O
osteosarcoma B-Disease
cells O
inhibited O
the O
cell O
proliferation O
, O
migration O
and O
invasion O
. O

DANCR B-RNA
was O
necessary O
and O
sufficient O
to O
control O
multiple O
malignant O
phenotypes O
of O
breast B-Disease
cancer I-Disease
cells O
in O
vitro O
and O
xenograft O
growth O
in O
vivo O
. O

DANCR B-RNA
and O
SNHG14 B-RNA
were O
also O
upregulated O
in O
gastric B-Disease
cancer I-Disease
and O
could O
promote O
cancer O
cell O
proliferation O
, O
invasion O
and O
migration O
. O

Loss O
- O
of O
- O
function O
experiments O
revealed O
that O
, O
in O
vitro O
and O
in O
vivo O
, O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
18289 I-RNA
knockdown O
inhibited O
the O
proliferation O
, O
migration O
and O
invasion O
of O
cervical B-Disease
cancer I-Disease
cells O
. O

knockdown O
of O
lncRNA O
PVT1 B-RNA
cause O
a O
marked O
reduction O
in O
tumor O
size O
in O
a O
human O
ovarian B-Disease
cancer I-Disease
xenograft O
model O
. O

Accumulating O
evidences O
show O
that O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
was O
dysregulated O
in O
various O
cancers O
, O
including O
melanoma B-Disease
, O
breast B-Disease
cancer I-Disease
, O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
, O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
, O
gastric B-Disease
cancer I-Disease
, O
colon B-Disease
cancer I-Disease
, O
and O
hepatocellular B-Disease
carcinoma I-Disease
, O
and O
amplification O
of O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
was O
associated O
with O
different O
clinicopathological O
features O
of O
cancer O
patients O
. O

Additionally O
, O
the O
data O
indicated O
that O
the O
increased O
expression O
of O
SUMO1P3 B-RNA
is O
significantly O
associated O
with O
tumor O
progression O
and O
the O
poor O
survival O
of O
patients O
with O
pancreatic B-Disease
cancer I-Disease
. O

Higher O
ACVR2B B-RNA
- I-RNA
AS1 I-RNA
expression O
is O
an O
independent O
adverse O
prognostic O
factor O
for O
overall O
survival O
( O
OS O
) O
and O
relapse O
- O
free O
survival O
( O
RFS O
) O
in O
liver B-Disease
cancer I-Disease
patients O
. O

AC114812 B-RNA
. I-RNA
8 I-RNA
was O
significantly O
upregulated O
in O
BC O
and O
could O
markedly O
facilitate O
the O
proliferation O
, O
migration O
, O
and O
invasion O
of O
bladder B-Disease
cancer I-Disease
cells O
both O
in O
vitro O
and O
in O
vivo O
. O

These O
results O
imply O
that O
A2M B-RNA
- I-RNA
AS1 I-RNA
might O
be O
a O
promising O
candidate O
prognostic O
factor O
and O
therapeutic O
target O
for O
breast B-Disease
cancer I-Disease
. O

A O
novel O
long O
noncoding O
RNA O
- O
LOWEG B-RNA
is O
low O
expressed O
in O
gastric B-Disease
cancer I-Disease
and O
acts O
as O
a O
tumor O
suppressor O
by O
inhibiting O
cell O
invasion O
. O

A O
novel O
long O
non O
- O
coding O
RNA O
lnc B-RNA
- I-RNA
GNAT1 I-RNA
- I-RNA
1 I-RNA
is O
low O
expressed O
in O
colorectal B-Disease
cancer I-Disease
and O
acts O
as O
a O
tumor O
suppressor O
through O
regulating O
RKIP O
- O
NF O
- O
kB O
- O
Snail O
circuit O
. O

A O
negative O
feedback O
loop O
between O
long O
noncoding O
RNA O
NBAT1 B-RNA
and O
Sox9 B-RNA
inhibits O
the O
malignant O
progression O
of O
gastric B-Disease
cancer I-Disease
cells O
. O

Further O
study O
suggested O
that O
lncRNA B-RNA
- I-RNA
PE I-RNA
downregulated O
miR B-RNA
- I-RNA
200a I-RNA
/ I-RNA
b I-RNA
by O
repressing O
the O
primary O
transcript O
expression O
, O
enhanced O
ZEB1 O
expression O
, O
and O
promoted O
epithelial O
- O
mesenchymal O
transition O
of O
hepatocellular B-Disease
carcinoma I-Disease
cells O
. O

17A B-RNA
is O
expressed O
in O
human O
brain O
, O
and O
we O
report O
that O
it O
is O
upregulated O
in O
cerebral O
tissues O
derived O
from O
Alzheimer O
disease O
patients O
. O
